Psychedelics, Neuralink, and Cannabis as a Holy Experience
Health & Wellness Issue
East Coast Tribe
Heats Up the Hamptons
Gearing Up for Cannabis in the NFL
Cannabis Gets Sexy: Taking It to the Sheets
Top 20 Must-Have Products
Innovator of the Year
Explores the Genome
Promoting Pet Wellness
Hemp-Derived THCV
Could be the Key to Normalizing Cannabis
On Top of the World: The Biggest Winners of European Legalization
FEATURE
The Gavita® 2400e- Broad dimming range for versatility, efficiency and intensity, 3520 individually tested diodes, Gavita® branded drivers. All assembled in the USA.
PAIRED WITH Brand new sensors from Titan™: Tali™ 3-in-1 VPD and Triton™ Substrate Sensors. Monitor and track EC, VWC, VPD and Soil temp and get valuable data, reliably and accurately, every time.
.
OPTIMIZED Through the Gavita™ EL3 controller– Unlock the complete feature set of the 2400e with full dimming range and dual zone control of up to 512 lights. PLUS, pull productivity optimizing data from your growing environment through the EL3.
Unify power, data and control under the bright lights of innovation. GAVITA® + TITAN™.
50% increase in BUD YIELD vs. HPS*
• Reliable, accurate data capture reduces hands-on verification
• Track EC, VWC, VPD and Soil temp
• Stable and quick can-bus communication technology
• Monitor, Control, and Adjust your in-grow tech from one screen
• Partnership between tech-forward brands Gavita® and Titan™
• Control 512 LED fixtures in two zones
• Sunrise/sunset dimming, high-temp dimming & shut-off
• Custom build/program full grow cycle schedules
• Data logging saves trend and performance data
• Updatable software
Welcome to the latest edition, focusing on cannabis and wellness. We are delighted to present a wide range of articles and features that explore the fascinating intersection of cannabis and health.
In this issue, we have assembled an exceptional team of writers who offer insightful and informative pieces on a variety of topics. We begin with an in-depth look at the latest research on the medical benefits of cannabis, including its use in treating chronic pain, anxiety, and other conditions.
In addition, we feature stories about the growing movement to legalize cannabis across the United States and around the world, as well as profiles of innovative cannabis entrepreneurs who are leading the way in this emerging industry.
Finally, we round out this issue with a look at some of the latest products and accessories for cannabis enthusiasts, including vaporizers, water pipes, and other gear that can enhance your cannabis experience.
At Cannabis & Tech Today, we believe cannabis has the potential to promote wellness and enhance overall quality of life. With this in mind, we strive to provide our readers with accurate, reliable information about the latest trends and developments in the cannabis industry.
We hope you enjoy this issue and find it informative, entertaining, and thought-provoking. As always, we welcome your feedback and suggestions for future articles and features.
PS — This letter was written by ChatGPT. Isn’t AI technology cool?
Extreme accuracy for small package weights
34
MICRO CCW-RV Multi-Head Weigher
Unsurpassed Accuracy
Easy to clean and operate
108
42
107
info@heatandcontrol.com | heatandcontrol.com
LOOKING BACK. PRESSING FORWARD. ALWAYS INNOVATING.
36 41 26
Cannabis & Tech Today is buzzing from a recent brick-and-mortar expansion.
Innovative Properties Worldwide (IPW), the parent company of Cannabis & Tech
Today, Innovation & Tech Today, Residential Tech Today, STEM Today, and Sustainability Today, opened the doors on its new location in downtown Denver, CO in Dec. 2022. IPW is onboarding several new staff members and looking forward to continued growth throughout 2023.
In addition to new staff in the sales and editorial departments, IPW welcomed Chief Operating Officer Ashley Manning to the administrative team. Manning brings years of experience and high-level connections from the cannabis industry to her role as COO. With Manning on board, IPW can offer our readers more inspiring insights than ever before.
SPECIAL THANKS TO:
Cannabis & Tech Today is now accepting applications for internship opportunities. Reach out to submit@innotechtoday.com if you’re interested in joining our team of award-winning content creators. This publication is entering its fifth year in print and your voice could help speak to a new generation of cannabis connoisseurs. Earn college credit, gain valuable experience, and share your passion by joining a motivated team of journalists.
The American Civil Liberties Union, NORML, Christian York, James Miller, Edna Dolan, Helen Freed, Tom Dolan, Randy Wilson, Nicole Widmer
This publication is dedicated to the dreamers, the innovators, the collaborators, and the doers – who can’t be bothered by those saying it can’t be done. Nicholas and Aria, the future is yours!
For print or digital subscriptions, visit cannatechtoday.com, or find us on popular digital newsstands and readers. All
PUBLISHER/EDITOR-IN-CHIEF
Charles Warner cwarner@goipw.com
CREATIVE DIRECTOR Shane Brisson shane@goipw.com
MANAGING EDITOR Patricia Miller
ASSOCIATE EDITOR Aron Vaughan
SENIOR WRITERS Ebby Stone
CONTRIBUTING WRITERS Hal Bishop
Rachelle Gordon
Davina Kaonohi
Tami Kamin Meyer
Sarah Lee Gossett Parrish
Nohtal Partansky
Alex Rogers
David Wallach
Deena Vallina
Zach Zerr
CHIEF OPERATING OFFICER Ashley Manning
CHIEF FINANCIAL OFFICER Mary Roche
DIRECTOR OF SALES
Steven Higgins
SALES & PRODUCTION MANAGER Surge Ali
ACCOUNT EXECUTIVES Marcus Culhane
Rachielle Gillstrap
Chris Howell
Thomas Johnston
EXECUTIVE ASSISTANT Tatiana Allensworth
VIDEO/PODCAST PRODUCER Alan Tuszynski
SENIOR DIRECTOR, DEVELOPMENT David Marble
DISTRIBUTION CMG
PRINTING Publication Printers
Cannabis & Tech Today is part of the PrintReleaf program helping to sustain and grow our global forestry system.
To learn more about unique advertising opportunities, please contact Steven Higgins at 727-771-5998.
@CannaTechToday
CANNABIS & TECH TODAY –Vol. 4/Issue 4, is published quarterly for $19.95 per year by Innovative Properties Worldwide, 3461 Ringsby Ct. #245, Denver CO 80216
POSTMASTER: Send address changes to CANNABIS & TECH TODAY, 3461 Ringsby Ct. #245, Denver CO 80216
within this publication are the property of their respective owners, and may not be individually identified in this publication.
Rachelle Gordon is a cannabis and psychedelics writer dedicated to educating the masses on the powers of plant medicine. She is especially interested in the potential these compounds have with regard to the treatment of neurological disorders. A graduate of Hamline University in Saint Paul, Rachelle currently splits her time between Minneapolis and Oakland. Her favorite cultivars include Tangie, GMO, and Lemon Haze.
Davina Kaonohi is the CEO & co-founder of Element Apothec. As a strategic leader and brand creator, Kaonohi is passionate about challenging the norm and making a difference with every company she has worked with. She is driven by a desire to truly make a difference both professionally and personally.
Tami Kamin Meyer is an Ohio-based attorney and freelance writer. A dedicated kayaker and dog lover, her byline has appeared in Forbes, MarketWatch, Better Homes and Gardens, and Business. com. She is in her second stint as a member of the Board of Editors of the Columbus Bar Association and served as marketing/ communications chair of the American Society of Journalists and Authors from 2018-2021. She tweets as @girlwithapen.
Sarah Lee Gossett
Parrish maintains a cannabis business law practice in Oklahoma. She is also admitted to practice in Texas and Colorado (single client). She has achieved Martindale-Hubbell’s highest AV rating for peer and judicial review, and is one of The Cannabis Law Report’s Global Top 200 Cannabis Legal Professionals. A member of the International Cannabis Bar Association and the National Cannabis Industry Association, Sarah Lee is a National Law Journal 2019 Cannabis Trailblazer. Learn more at www.slgparrishlaw.com.
Nohtal Partansky is the founder and CEO of Sorting Robotics. He is a serial entrepreneur and former NASAJPL engineer. At NASA-JPL, Nohtal was a cognizant engineer on the MOXIE project, an instrument currently on the surface of Mars producing oxygen from the Martian atmosphere. After leaving NASA-JPL, Nohtal founded Sorting Robotics with his two co-founders, Cassio Dos Santos Jr. and Sean Lawlor. Sorting Robotics builds innovative, AI-driven equipment for cannabis manufacturers and vertically integrated brands.
Alex Rogers is the founder and CEO of the International Cannabis Business Conference, which offers world-class industry networking as well as investment and capital opportunities. The International Cannabis Business Conference has upcoming events in Barcelona and Berlin. Visit internationalcbc.com to learn more.
Deena Vallina is the CEO of Bud Counters and a Dope CFO VIP Cannabis Accountant trained in the cannabis industry. Bud Counters is headquartered in Las Vegas and serves the cannabis industry Nationwide. Deena serves on the Board of Directors of The Chamber of Cannabis, a 501(c)(3) organization based in Las Vegas, promoting cannabis legislation and advocacy.
David Wallach is an awardwinning writer, television producer, podcast host, marketing executive, fan of anything outdoors, and bacon lover. To see more of his work, check out www. davidwallach.net.
Zach Zerr is the director of product development for Bloom Distribution. He also writes about cannabis and hemp with a focus on consumer education.
Editor’s Note: Cannabis & Tech Today is seeking writers from all backgrounds and ethnicities. Interested applicants inquire through submit@innotechtoday.com.
By Charles Warner
The Lemonhaze Executive Golf Invitational that happened right before MJBizCon last November is not about golf. I mean, it’s golf — and exquisite golf at that, but to describe it as a golf tournament does not do it justice. It is an elite, supreme networking event. And oh, by the way, there was some once-in-alifetime golf that also took place at Cascata Golf Club that day.
It all started at about 8 a.m. when golfers piled into long, black, bus-style limos at the ARIA and other resorts. Attendees were greeted by friendly faces and sponsors offering beverages, including champagne infused with terps. The quick ride to Cascata, just outside Sin City, began and so did the networking. Seriously, cards and ideas were exchanged before anyone hit the links and all the people were heavy hitters in the cannabis space.
Once everyone arrived, there was a hot breakfast and full array of beverages served up, along with a chance to mingle with sponsors and other golfers before tee-off. There were celebrities mixed in with the executives, along with a very eager and helpful staff at the course. Speaking of the course … WOW.
The course at Cascata cost about $70 million and it looks like it. When it opened in 2000, it was an exclusive playground for the casino whales 22 miles away, but it is now open to the public. It’s ranked in the top 50 of all public courses. The views were amazing, and as if on cue, at the first hole we were greeted by bighorn sheep meandering around the flag. Breathtaking views, manicured courses, and wildlife made for the type of environment where you only could see your hole and the rest of the course, and the world just disappeared while you played.
Each hole offered an opportunity to chat with sponsors, grab samples, and network with other golfers. The pace of play was solid for a best-ball tournament and they provided fresh food at the ninth hole — including a “surf and turf” steak sandwich and lobster roll. You don’t really want for anything before, during, or after the event, and it was the perfect way to ease into a busy week during MJBizCon.
Sponsors were thoughtfully selected to complement certain elements of the event and when it was all said and done, Brian Yauger, CEO of Lemonhaze, cornered the market on executive networking and fun — all rolled into one.
If you are looking for an experience of a lifetime, first-class hospitality, and worldclass golf with the cannabis industry’s biggest names — you can’t do better than Lemonhaze. Cannabis & Tech Today gives it five stars and can’t wait for next year! ❖
Breakthrough, patented technology for cannabis and hemp growers.
ALL NATURAL • PHARMACEUTICAL GRADE • SAFE
INSECTICIDE SPORICIDE FUNGICIDE
Knock-down and kills botrytis, wilt and fusarium
Kills and prevents powdery mildew and phythium rot
NEMATICIDE
Kills worms, mites, aphids and thrips
Root stimulant and nematicide
Operate an e ective IPM (Integrated Pest Management) regimen with GroPro products. 0 REI, 0 PHI, and MRL exempt
The foundation of GroPro’s revolutionary technology is our proprietary AMPx™ production process. Our tightly controlled manufacturing method starts with plant extracts, sourced from our facilities, then passed through our AMPx platform. AMPx technology allows us to re ne these plant-based oils, the building blocks of our pesticide line, to the highest level of purity in the industry. The AMPx process then micronizes these highly puri ed, highly concentrated extracts and reduces them into an ultra ne micron designed for optimal performance. The AMPx process results in products that are highly “bio-available” and “target-speci c”, delivering more activity with fewer total active ingredients.
Safe for indoor and outdoor crop control
When used as directed.
This history lesson is crucial, so don’t tune out! Ashes containing THC suggest cannabis was used medicinally as early as 400 AD. In the early 19th century, cannabis was described in the United States Pharmacopoeia as a patent medicine. It wasn’t until 1970 that it became federally illegal as a Schedule I controlled substance with “no accepted medicinal use.” Let’s challenge that notion with a closer look at the numbers around medical cannabis use in America.
Medicalcannabis islegalin U .S .Statesandthe DistrictofColumbia. 39 39
Source: mjbizdaily.com
1996
California becomes the first state in the nation to legalize medical cannabis with the passage of Proposition 215 (the Compassionate Use Act). Source: academic.oup.com
91% of adults who have ever consumed cannabis did so for health and wellness purposes.
75% prefer holistic solutions over pharmaceuticals.
67% of physicians favor nationwide legalization of medical cannabis.
Source: cfah.org
74% (248 million) Americans now have access to some form of legal cannabis.
Source: cfah.org
Backgrounds/Icons via iStockphoto.com
4.7 million registered patients used medical cannabis in 2022.
Source: cfah.org
44% use cannabis to reduce stress.
62% prefer cannabis over pharmaceuticals to treat a medical issue.
52% use cannabis to relax.
49% use cannabis to help with sleep.
41% use cannabis to reduce anxiety.
88% said consuming cannabis improved their overall well-being.
Source: The Harris Poll on Behalf of Curaleaf Holdings
COMPREHENSIVE DETECTION AND REPORTING capabilities for intrusion, medical emergencies, water leaks, high/low temperatures, and more.
MONITOR ENVIRONMENTAL CONDITIONS such as temperature and humidity. A great option for wine cellars, server rooms, coolers/freezers, etc.
DOOR & GATE CONTROL for multiple entry points with restrictions by area, user, and/or schedule.
INTELLIGENT CONTROL AND AUTOMATION including lights, thermostats, integrated locks, overhead doors, fans, pumps, irrigation, water valves, and more.
STAY INFORMED WITH EMAIL/TEXT ALERTS for system status, alarm events, unsatisfactory conditions, and other events.
CONTROL M1 WITH POPULAR SMART DEVICES with flexible apps and software options for every user and budget.
By Ebby Stone
Inflammation causes backaches, menstrual cramps, swollen joints, and many other ailments. That’s why nonsteroidal antiinflammatory drugs (NSAIDs) like ibuprofen are among the most commonly used drugs in the world. If you’re trying to move away from reliance on NSAIDs, cannabidiol (CBD) can be an effective alternative. Before jumping aboard the CBD train, there are a few key considerations.
per milligram, and information about mold and mildew as well as the presence of heavy metals.
option for obtaining rapid relief with higher doses. There are loads of CBD gummies available, but they are sugary and may contain animal byproducts like gelatin. Gel capsules are an excellent alternative to gummies as they have no taste and can be quickly scaled to the appropriate dose. A transdermal patch can also be a quick, effective delivery method that offers prolonged pain relief. Similarly, salves and creams can target the source of the irritation with a quick onset.
“Start low and go slow” is an apt mantra for most cannabis products. But, many people don’t feel relief from non-THC CBD until nearing the same milligram dose as what is available from over-the-counter medications like ibuprofen. Many NSAIDs contain at least 200mg per tablet. Conversely, many CBD products are available in small doses, like 5mg per capsule. You can start low, but feel free to increase your dosage until you notice a pain-relieving effect.
CBD is available in virtually every gas station and corner store. But not all products are equal. Look for certified organic products. These are grown without pesticides and contain fewer toxins that may aggravate inflammation.
Search the packaging for a certificate of analysis QR code. Quality products are potent, pure, and shelf stable — with test results to prove it. Reputable companies make it easy to find test results. If you don’t see it on the packaging, you may find test results on the company’s website. If not, it’s best to keep searching for a more transparent company. Tests should include the CBD to THC ratio, potency
One incredible benefit of legalization is product diversity. You can find CBD in practically any form. Tinctures are an excellent
You may hear people say CBD is only effective for mild pain. In this author’s experience, a higher dose is necessary for adequate pain relief. Find a delivery format that works for your lifestyle and preferences. A transdermal patch is discreet and continuous for a day at the office. Gel capsules offer a familiar “medicine cabinet” approach to relief. And tinctures are helpful for any occasion when seeking faster effects. While the milligrams per dose and the preferred delivery method will be different for everyone, the necessity of a pure, quality-tested product is universal. Do your diligence and before you know it, you could be leaving NSAIDs on the shelf and opting for a liver-friendly CBD alternative. ❖
Adult-use cannabis legalization has garnered significant attention to start this decade in Europe, and rightfully so. The effort to legalize cannabis for adult use is not new on the continent. However, the momentum for legalization in Europe is greater now than ever before.
In Malta, adult-use legalization is already a reality. This month, regulators will begin accepting applications for non-profit cannabis clubs to supply consumers. Adult households in Malta also have the freedom to cultivate up to four plants thanks to a limited legalization measure that passed in late 2021.
As adult-use legalization grows, it is as important as ever to be mindful of suffering patients throughout Europe and to ensure their needs aren’t lost in the hype. Every cannabis advocate across the European continent needs to push for safe access and sensible medical cannabis policies to ensure no suffering patients are left on the outside looking in.
Fortunately for patients, when adult-use cannabis legalization measures are passed, nonregistered patients win. Using Malta as an example, every adult who suffers from a condition that can be treated by cannabis can now legally cultivate their own medicine. Once non-profit clubs launch, they will be able to access their medicine that way as well.
The boost in safe access provided by adult-use legalization is not limited to just Malta. In nearly every jurisdiction that permits medical cannabis, certain conditions qualify a patient for a medical cannabis program while other conditions are not on the “approved” list. When those jurisdictions go completely legal, any patient of legal age can purchase cannabis, regardless of their condition.
How medical cannabis policies and regulations are affected by potential legalization is always a major topic at the International Cannabis Business Conference events in Barcelona and Berlin and that is sure to be the
case in 2023. Both Spain and Germany are home to large medical cannabis communities and both nations are trending toward full legalization.
Spain and Germany are at critical junctures when it comes to cannabis policy. Germany, particularly, appears to be on the cusp of launching the world’s largest adult-use industry sooner rather than later. The nation’s eventual industry will serve suffering patients in Germany as well as patients from other nations seeking easy access to cannabis treatments. Lawmakers need to be mindful of this and craft policies and regulations accordingly.
What medical cannabis in Europe looks like five to 10 years from now will be much different than how it looks today. As adult-use spreads, medical cannabis reform will spread with it, albeit in an indirect fashion. This growth will ultimately benefit patients, which is always a good thing. ❖
The CBD for animals category is exploding, but can cannabis help pets the way it helps people?
“My pet is a member of the family.”
You’ve probably heard this statement before, or even said it yourself. Nearly 70% of American households have a companion animal, with dogs and cats being by far the most popular. Many pet owners often go to great lengths to ensure their furry friends are happy and healthy, whatever the cost.
As more people benefit from cannabis, particularly CBD, there’s a growing demand for products formulated for animals. Scientific research on cannabis and animals remains extremely limited, but anecdotal evidence has revealed a wide range of benefits, from helping to treat separation anxiety to reducing chronic pain, driving an explosion in sales.
The pet CBD category was valued at $629 million in 2021, according to analysis from the Brightfield Group. It’s expected to balloon to over $1 billion by 2025. The same report showed a significant uptick in the number of animal owners discussing CBD with their veterinarians, with more people than ever wondering: How can cannabis potentially help my pet?
It’s worth noting that all mammals (not just humans) have an endocannabinoid system, with CBD showing similar benefits for animals as those found in people. And while the majority of research into CBD focuses on what it can do for humans, a few studies have focused on CBD’s potential for pets.
Findings from a 2018 trial published in the journal Frontiers in Veterinary Science revealed administering CBD twice a day may help ease symptoms in dogs with osteoarthritis. A 2019 study published in the National Library of Medicine also centered on canines; it showed CBD decreased seizure activity. Additional studies on dermatitis and anxiety had mixed results, with scientists concluding that CBD shows promise but requires additional testing.
Kurt Kinneman, owner of Bad Apple Pets, said most people seek out his company’s CBD dog treats, equine pellets, and pet tinctures as a way to help their animals relax.
“The main use case I see is anxiety, whether it’s separation-related or events like vet visits or the Fourth of July,” Kinneman told Cannabis & Tech Today. “Joint conditions and arthritis would be second, followed by itching.”
Kinneman attributes the success of his fullspectrum CBD products to the anti-inflammatory properties of the
cannabinoid, noticing that when animals have fewer symptoms, they’re able to feel more at ease overall.
“We like to say ‘calm bodies, calm minds,’” he said.
Word-of-mouth has been a key driver of customer acquisition for Bad Apple Pets, but Kinneman hopes more veterinarians will soon join the conversation.
Currently, most veterinarians rely on anecdotal information about CBD for pets gathered from examinations or owner reports. A recent survey revealed that over half observed CBD being at least somewhat helpful for chronic pain in their patients, and 75% reported the compound was useful for reducing anxiety and seizures.
Despite the promising results, only 45 % of veterinarians surveyed felt comfortable discussing CBD with their clients. However, the vast majority supported removing cannabis from Schedule I status and increasing scientific studies.
“We need more research and regulation of the space to help legitimize it,” Kinneman argued. “CBD is already helping a lot of animals, but there are so many more who I believe could really benefit.” ❖
Crops
Cody Henderson, Cannabis Facility Manager
THCV is quickly gaining notoriety for its potential as an appetite suppressant, which could revolutionize how Americans view cannabis. Like most cannabinoids, more research isn’t just needed — it’s required. However, if early indications are correct, this hemp-derived cannabinoid may be the key to the long-overdue normalization of cannabis in the United States.
What
Delta-9 Tetrahydrocannabivarin, or THCV, is a cannabinoid with psychoactive properties that produce energetic effects, including alertness, motivation, focus, and euphoria. However, unlike THC, THCV is considered nonintoxicating in low doses. THCV is a rare cannabinoid found in both hemp and marijuana but has become more readily accessible since the Farm Bill was enacted in 2018.
When THCV is used on its own, users may experience a euphoric boost that is not as powerful as a cup of coffee but is much clearer than the typical high associated with THC. While appetite suppression sounds intimidating, user reports paint a much more complex and interesting picture.
THCV’s potential as a “diet supplement” is beginning to gain traction, but like most cannabinoids, reports indicate that it has numerous effects. Despite being a more energetic cannabinoid, THCV is often credited for its calming benefits, including reducing stress and preventing panic attacks. Researchers believe THCV also has neuroprotectant properties. However, THCV’s ability to suppress appetite is the most significant cause for excitement because it has the potential to shift our nation’s perception of cannabis dramatically. Beyond making significant strides toward federal legalization, THCV can also carve out a path towards normalizing cannabis if it becomes a widely accepted weight loss treatment.
THCV acts as an antagonist to the CB1 receptors, which has appetite-suppressing effects. Conversely, THC binds to the CB1 receptors triggering numerous responses, including an increase in appetite. However, our understanding of the endocannabinoid system is still relatively basic. While we can measure cause and effect, we do
not fully understand why each cannabinoid affects us the way that it does.
Users report that THCV reduces food cravings and consumption without inhibiting appetite or upsetting the stomach. These reports are notable because they reflect our current understanding of the endocannabinoid system’s primary responsibility to promote homeostasis and balance within the body. Instead of forcing you to lose your appetite, it appears as though THCV naturally regulates your appetite to help you consume what your body needs without overdoing it.
Like other cannabinoids, the effects of THCV vary between individuals and doses. In small doses, THCV appears to impact everything from appetite suppression to blood sugar levels positively. However, THCV can be psychoactive in high doses and even increase appetite.
So while the potential of this cannabinoid is something we should be excited about, it is not a one size fits all solution. But, with research ongoing and more people willing to trust hemp, this once-rare cannabinoid may be the key to the future of cannabis in America. ❖
By Nohtal Partansky
Across the U.S., pre-rolls are rising in sales and popularity among cannabis consumers. The convenience of pre-rolls allows consumers to avoid the work of rolling their own, a preference that ranks high with the market’s target audience.
But as much as pre-rolls are gaining market share, not all things are looking up for this product category. The products themselves are just as quickly gaining a reputation for hit-ormiss quality and a lack of overall consistency.
This poses a problem for industry operators — one that robotics could potentially solve.
There’s no question about it: Pre-rolls are gaining traction in sales. Headset, a cannabis analytics company, recently reported that preroll sales increased 38.9% from 2020 to 2022. Another report shows that in California, the number of online carts that only have pre-rolls went from 47% to 53% in just one year.
But that’s not all. Infused pre-rolls are having a moment, too. Coinciding with the trend toward desiring convenience is a heightened demand for potency. To keep up with the trends, brands are now infusing pre-rolls with cannabis oil or
concentrate to boost potency and meet these unique customer needs. Senior data analysts at Headset called infused pre-rolls the “segment to watch in 2022,” considering the category took over as the second-largest, with sales doubling in both years.
Infusing pre-rolls adds a whole new element for operators to manage in producing a uniform product that delivers a consistent experience for consumers. Lacking consistency is one of the fastest ways to self-sabotage a brand. To avoid doing so, facilities are increasingly turning to technology to automate, fine-tune, and elevate the way pre-rolls are made.
The perfect pre-roll is an art form, as simple as it may appear. The flower has to have just the right consistency and be packed just the right way to deliver the smooth, even burn that consumers crave. Today, pre-roll manufacturers are finding it incredibly difficult to achieve this type of precision and accuracy.
That’s where robotics and automation technology enter the conversation. With the right equipment, brands can calculate exact
ratios and fine-tune mechanisms to produce the perfect pre-roll with every fill. This not only allows pre-roll manufacturers to automate and scale processes to increase their bottom line, but it improves the end-consumer experience too.
Most operators struggling to make a profit and keep staff might think this type of technology is out of reach. But even though it might take a genius to design and engineer robotics-powered pre-roll infusion technology, it doesn’t take a genius to use the finished product. It’s not necessary to hire new teams to operate automated systems, which is another benefit of implementing automation technology to improve consistency and quality.
As the industry evolves, so will product quality and the advanced processes it takes to deliver pre-rolls people can depend upon. We’ve seen concentrate quality improve over the years, solventless goods take over the game, and now it’s time for pre-rolls to evolve to meet market demand. So don’t give up on pre-rolls just yet and stay tuned as brands transform from hit-ormiss to tech-powered quality. ❖
Pay attention. Your survival could depend on it. Cannabis consumers, I’m talking to you. How’s the environment looking? Pretty bleak. Is the economy rock steady? Far from it. Let’s not even talk about the quality of global leadership right now. These elements are the foundation of a seemingly abstract term — ESG. It stands for Environmental, Social, and Governance, and it affects the fate of mankind.
If corporations don’t start taking a hard look at how they’re addressing ESG on a micro scale, it spells disaster on a macro scale. Consumers matter here. Money, the money in your pocket right now, tells a story wherever it goes. It describes what you care about and cries out your hope for the future. When people invest in companies with ESG frameworks, they’re investing in responsibility — in green grass and blue skies. ESG-focused companies are the foundational elements of a tomorrow we can all thrive in.
They’re cementing themselves as the only way to do business. And they’re often the best way to attract customers and investors to one’s business model.
Geoff Trotter, a co-founder of ESG and sustainability advisory firm Regennabis, believes companies can create an ESGcentric business model without losing money. “You can create massive profitability in this space and do good. They’re not mutually exclusive,” Trotter noted during a recent interview with Cannabis & Tech Today.
By Ebby StoneAs purchasers, you have a voice. As business owners, you have a choice. Companies can decide right now if they want to be part of tomorrow’s economy. Investing in ESG frameworks tells customers you want to exist in 20 years. It tells investors you’re looking ahead at the regulations sitting in dusty stacks on bureaucrats’ desks across the globe. These requirements, to do one’s best for the environment, for society, and as leaders, are more than a moral imperative. They’re quickly becoming law.
Any company looking to live out the capitalist dream of global expansion should also note the demand for ESG is much louder in the international marketplace. America is sort of whispering about it. Other nations are shouting it. Trotter touched on this point, “If you think you can exist in a vacuum in the United States, you have another big challenge coming if you are aspiring then to operate, for example, in Germany or Europe. Generally, ESG performance is more than expected, it’s now a legal requirement.”
So, whether you’re a business owner or a consumer, spend your dollars thoughtfully. If you’re a buyer, buy with the knowledge that your choices will affect your kids’ lives. If you’re a business, consider the planet, its people, and your purpose in daily operations. Businesses and the buyers that support them have one thing in common — humanity. We’re part of the same human race watching the Doomsday Clock ticking down. Let’s set back that clock and make an effort like our lives depend on it. ❖
It’s Time to ESG Like Your Life Depends on It
Cherissa Jackson’s voice radiates confidence and compassion. She’s thoughtful, eloquent, and seems to have a purity of purpose that’s rare in American society. While she spreads her time between numerous projects, she unifies her focus by thinking about her three Ps: passion, purpose, and people. She applies this theme to every endeavor, and it’s most apparent in her work with We DeCode, a venture she launched in early 2022 to bring precision wellness to its clients.
We Decode is a DNA-testing service specializing in predictive, customized analysis. While Jackson doesn’t market We Decode DNA kits as “cannabis kits,” she is offering a unique insight into the interaction between cannabis and an individual’s endocannabinoid system based on genomic profile. We Decode uses patented technology to inform clients which cannabinoid formulations are most effective for their specific genetic profile. Do you need more CBD and less THC? We Decode can tell you. The company also pairs these insights with peerreviewed research studies about cannabinoids or genomic markers
so clients understand what their body needs and how to approach those needs with care providers.
Jackson created the company after a discussion with a fellow veteran who had replaced pharmaceuticals with cannabis. As a veteran who spent 23 years on active duty, including 10 years as a combat nurse in the U.S. Air Force, Jackson struggled with PTSD. When she realized cannabis could be a gateway to healing for veterans like herself, she embarked on a mission of discovery. She enrolled in the Medical Cannabis Science and Therapeutics Master’s program at the University of Maryland. Jackson said the program allowed her to “dive deeper into the history, the science of the plant, and how its efficaciousness is helping and changing the lives of so many people.” In this Innovator of the Year profile, Jackson reveals the science behind her innovation and discusses her hopes for the future of healthcare. This interview has been edited for length and clarity.
Cannabis & Tech Today: What are you hearing from other veterans using medical cannabis?
Cherissa Jackson: Veterans who are taking the We Decode DNA test are discovering that they are not taking the most precise or the best products based on their DNA. Many of them have shared their stories of entering the cannabis space because they didn’t want to use and have stopped using pharmaceuticals because they didn’t like the way it was making them feel. Some felt numb, some felt like they weren’t able to be present — present for their family, present for themselves, just not even present in the moment because of the way the pharmaceuticals were making them feel.
And then on the flip side, those veterans using opioids, they too started having those side effects that were making them paranoid and many of them cannot cope with those side effects. And as most people would know, there’s a suicide epidemic where 22 veterans take their lives each day based on their PTSD mental health challenges and also opioid and substance abuse. So to hear these veterans say that they are actively participating in their health by making their own decisions and choosing not to be
on pharmaceuticals and choosing plant medicine has been something that I think is happening more readily than the community actually knows.
C&T Today: When did you realize there was a need for a program like We Decode?
CJ: We launched on April 20, 2022. The need came in ’21 after I started my master’s program at the University of Maryland. I was surrounded by other students that were thinking about entrepreneurship and then constantly facing or being in the same place with veterans sharing their stories. Then I think I read a statistic that said, “It takes on average between three to six months, if not longer, for someone to find that sweet spot, find that secret sauce, if you will, of products that work for them. And by the time they discover the right particular gummy, tincture, or flower, folks have spent upward of five to $7,000 on products.” So imagine getting a product and it’s not working, and you’re going back trying and trying again to find a product that does work for your pain, your anxiety, your depression — and it’s not working.
It’s not like you can take the products back to the dispensary to try something else. So it was that statistic that I thought, “Hmm, if there’s a way to help the community, to help veterans find their products sooner, we can save them time and we can save them money.” And that was the catalyst that sparked me to create We Decode.
C&T Today: How did you discover which genome sequences would correspond to specific cannabinoids or terpene profiles, and vice versa?
CJ: It’s a matter of finding those particular markers that we’ve discovered for our wellness kit that are going to give us the most health information that we target. By targeting those particular genomes and those genes that we’re going to sequence using a patented IP algorithm, we’re able to give that precise prediction on which product’s going to work for individuals.
Our test doesn’t provide information on all the cannabinoids because all of the cannabinoids have not been researched. What has been researched in abundance are THC and CBD. So we can predict and give people precise matching based on those two cannabinoids.
Of course, there are a hundredplus terpenes out here, so we’re focused on those that have been researched. Every recommendation the report gives a customer has a scientific article or some type of scientific attachment where a person can read about that particular gene and why this is specific to them. We pair the recommendation for a
particular cannabinoid or terpene with a peer-reviewed scientific article.
C&T Today: How have you seen your health impacted by understanding your genetic profile?
CJ: The biggest thing is backing away and not using as much THC. When you enter the cannabis space, unless you’re knowledgeable about your health, you can easily take too much THC when your body may not need that. So for me, having to see that my body doesn’t need the amount of THC I was taking was so helpful because I never needed that euphoric effect. It confirmed that my body doesn’t need as much THC as possible. With the entourage effect, you want to get the whole plant to be effective, so my body does need some THC, but the amount I was taking prior to my DNA test far surpassed what my body needs.
So the greatest thing I think the reports offer customers is not only autonomy but helping them understand their whole health. We’re branding ourselves not as a cannabis kit, but as a wellness kit because it provides information about your whole health. It tells you about your metabolism. It tells you if you had an opioid dependency or alcohol dependency, or if there are any concerns about gluten or lactose intolerance. It provides a framework about their health that they can then take to their provider and their provider can gauge their care plan, they can gauge how they monitor their health by using our reports.
C&T Today: What are the biggest barriers preventing someone from pursuing DNA testing?
CJ: Healthcare is going towards precision medicine, and precision medicine comes from DNA testing. In most hospitals when
“ healthcare is going towards precision medicine and precision medicine comes from dna testing.”
providers are uncertain of what’s happening with the patient, they tend to steer in the direction of doing a DNA test. I think the biggest hurdle for most patients and customers is trusting who has their DNA, which is why we have a HIPAA-compliant portal, so I don’t get to see the patient’s results. No one but the patient gets to see those results.
C&T Today: What prevents people from exploring cannabis as a medical treatment option?
CJ: I think the stigma is still out there and it’s going to take folks like myself, the cannabis community as a whole, to help that shift in the community. When we’re talking about it the narrative has to change because the plant has changed over the years. What the war on drugs did to the persona of cannabis and what the war on drugs propaganda did to change the perspective of what this plant can do has been damaging. Now we’re having to undo that damage to educate the community about the efficacy of the plant and use science as a means to support the efficacy. That is what we’re out here doing as advocates.
So I think that’s the biggest challenge, overcoming that stigma. And when people are wanting to try it, it shouldn’t be a rolling of the eyes or any type of negative comments about someone trying the plant when our bodies were designed for it. That’s the purpose of the endocannabinoid system, is to uptake plant cannabinoids. So I think it’s just having that narrative be more positive out in the community and having people who are talking about this plant
talk about it in a more positive light, sharing the good that this plant is doing, sharing the efficacy of this plant, and showing how it’s saving and changing the lives of customers.
C&T Today: What does innovation mean to you and what inspires you to innovate your space?
CJ: I think my inspiration comes from really thinking about my three Ps. The three Ps that I always look to for being creative, being innovative, is making sure I align
myself with my three Ps. My three Ps are passion, purpose, and people. So if anything that I’ve tried to pursue does not align with those, then it’s not something I’m even interested in. For me, innovation is key to saving and changing the lives of customers or patients. Being in the healthcare field, I’ve seen how innovation has saved lives, coming from seeing veterans on the battlefield, seeing them at Walter Reed, and being at level one trauma centers where
you have state-of-the-art technology and seeing how that technology is being used to save lives.
I’ve always been interested in and intrigued by innovation because I know what change it can do in the healthcare system. I’ve seen it firsthand, having seen veterans who have multiple amputations, and seeing them live their best lives now. Living their best lives, swimming, skiing, and just doing the unthinkable though they don’t have limbs. Innovation is so important for giving people the quality of life they deserve. For me, being an innovator, it’s who I am because it aligns with my three Ps: passion, purpose, and people. I see and have seen firsthand what innovation can do. I will never forget my encounters with those veterans who were given innovations and they’re living their best lives now. That would be what inspires me to be creative in an innovative space.
C&T Today: Do you have any final thoughts you’d like to share?
CJ: What I want readers to know is this technology is the route that healthcare is going. Whether or not you’re using it to figure out your cannabinoid match or your terpene matches, that’s not the overarching goal here. The overarching goal here is a formula. The formula is early detection (our DNA test), plus treatment (either through holistic means or through cannabis plant medicine), which equals a decrease in healthcare costs, which saves lives. When you look at that formula, that’s exactly what technology is. That’s exactly what innovation is. ❖
“ innovation is so important for giving people the quality of life they deserve.”
Sustainability has become a buzzword in recent years with so many companies claiming to prioritize it in their operations. However, true sustainability goes beyond simply reducing packaging or using ecofriendly materials. It also encompasses ingredients, product formulations, and the company’s commitment to supporting sustainability through transparency and charitable partnerships.
The wellness and beauty industry, which includes CBD and cannabis products in personal care, skin care, and supplements has been growing at an unprecedented rate, especially post-pandemic, as people focus on their well-being. But with that growth comes the potential for additional negative impacts on the environment via the increase in sourcing and production of ingredients and packaging. Statistics report that at least 120 billion packaging units are produced annually by the beauty and wellness industry, most of which are not recyclable. A report by The Environmental Protection Agency noted that close to 70% of
the 14.5 million tons of plastic containers and packaging the U.S. generated in 2018 ended up in a landfill.
Consumers concerned about the environment are factoring sustainability into their product choices. According to L.E.K. Consulting’s Consumer Sustainability Survey 2022, U.S. consumers rate sustainability fourth in importance for purchasing products, and 56% of U.S. consumers would be willing to pay 35-40% more for sustainable products. Additionally, consumers are concerned about product manufacturing processes and how they impact the ecosystem — a fact that is pushing companies to adopt eco-friendly practices. By incorporating sustainability into their operations, brands can attract and retain customers who value environmentally-friendly products.
Sustainability should be an integral part of a brand’s mission, not only because it is the right thing to do, but because it can ultimately benefit
both the environment and the well-being of its customers. Fortunately, there are multiple paths brands can take in their quest for sustainability. To truly prioritize sustainability, companies must take a holistic approach that considers many factors. The time to start going green is now!
Consider the impact your business operations have on the future of the planet and take steps to lower impact throughout the entire supply chain — from raw ingredient sourcing to sustainable packaging and shipping of the final product. Support charitable organizations such as 1% For The Planet and Our Forest, which support global reforestation efforts by planting a tree with every order received. Applying for B Corporation status is another way to show your brand’s accountability and commitment to sustainability. It’s also important to understand this is an ongoing process that can continually be improved upon. Consider the following business practices that may help on your journey toward sustainability.
Sustainable ingredients are those that won’t harm the planet or human health. Non-toxic, organic, and natural ingredients are sustainably grown and responsibly harvested, creating less of an impact on the planet. This is more pronounced when compared to chemicals such as parabens and phthalates, which can damage human health and cause ecological harm.
Consider the ingredients themselves and how those ingredients are sourced — including the workers’ treatment and culture. This requires a brand to ensure its suppliers are committed to positive social and environmental impact, understand what’s going on within its supply chain, and pay a fair price for the raw materials and goods.
It’s important to use product packaging that minimizes waste and/or is recyclable. Sustainable packaging includes glass, sugar cane ethanol plastic, biodegradable films, and post-consumer recycled cardboard. As materials evolve and more sustainable options become available, brands should continue to change and improve their efforts. While companies can’t control what happens to packaging once it’s in the hands of customers, they can educate shoppers on how to recycle and dispose of packaging sustainably through blog posts, emails, and other content.
It isn’t enough to just state that you are sustainable; consumers need to be able to trust your brand through meaningful action and communication. Some brands, like Element Apothec, have earned Cert Clean Certification for eligible products. Clear For Me is another organization that will validate every ingredient and its purpose. Third-party testing for every product ensures they never contain any pesticides, toxins, or heavy metals.
Brands can do their part by supporting charitable organizations that have a social or environmental impact. Consider pledging a portion of revenue to charities. It’s inspiring for
businesses and customers to see other ethical brands with a dedicated giving policy. For example, 1% For The Planet members give one percent of their earnings to support environmental charities. Others emulate this philosophy by directly giving proceeds to social or conservational charities or by simply using their platform to support causes they are passionate about.
Sustainability should be an integral part of any company’s mission. Not only because it is the right thing to do but because it aligns with their core values and can ultimately benefit both the environment and the company’s long-term success. Brands have a responsibility to minimize the negative impact of their operations on the environment and society. Incorporating sustainability into their operations is one way to do this. By prioritizing sustainability, brands can ensure that they are operating in a way that is environmentally and socially responsible. By embracing sustainability, companies can improve their reputation and brand image and attract and retain customers who value environmentally-friendly products. ❖
Although wellness is not a new concept, a global pandemic helped bring it once again to the forefront. Not only are more consumers interested in wellness, but they are now viewing it through a wider and more sophisticated lens. It is no longer just about fitness and nutrition, but also overall physical and mental health. There are a wider variety of products available and customers are demanding clean, natural, products designed to improve health and well-being.
So, what does this have to do with cannabis? Everything! As perceptions change and social stigmas across age groups relax, a new sector is emerging. Somewhere between strict, medical-only use, and solely recreational use, is wellness. We’re finding the cannabis industry targeting the self-care and wellness-minded consumer. This lucrative subsection of the billion-dollar cannabis industry will be instrumental in achieving mainstream acceptance of the plant. Furthermore, MJBizDaily noted these wellness products have a greater appeal to those that intend to, but currently do not use cannabis.
Whether treating a specific medical condition, relaxing, creating mindfulness, exercising, substituting for other (less healthy) activities, or utilizing it as a beauty regimen, individuals are using cannabis for a variety of reasons and redefining wellness.
Many products that fall under the wellness label are categorized as medical. As this suggests, medical cannabis is splitting into two separate markets, medicinal to treat specific ailments, and wellness products for health and overall well-being. Executives believe there is money to be made by capitalizing on both.
In 2021, 42% of cannabis users identified as medical consumers and 95% believed their conditions had improved with cannabis, with 56% reporting significant improvement. The top five medical considerations consumers bought cannabis to treat were anxiety (41%), arthritis (29%), pain (29%), insomnia (18%), and migraines (17%). Hundreds of millions of Americans experience each of these conditions; 20 million+ anxiety, 51 million+ arthritis, and 140 million+ pain, and many of them will consider trying it — particularly if existing consumers overwhelmingly report improvement.
Wellness products for overall well-being, not specifically used for treating a certain condition, can be further delineated into subcategories such as relaxation and mental health, fitness, substitution, and cosmetics. Consumer data from a research study conducted by New Frontier Data found nearly 23% of current cannabis consumers use cannabis to improve their overall health and wellness.
Wellness-specific uses for cannabis rank highest for relaxation (67%), stress relief (62%), reducing anxiety (54%), improving sleep quality (46%), and pain management (45%). While many wellness uses are similar to medical uses, the key difference is that wellness consumers use cannabis for overall mental and physical wellbeing and support as opposed to use for specific conditions. Men and women both report relaxation and stress relief as their leading reasons for cannabis use.
The stereotype of the unhealthy, sedentary stoner is no longer accurate. A study using 10 years of data collected by the National Health and Nutrition Examination Survey (NHANES) found that any lifetime cannabis use was associated with higher odds of physical activity. New Frontier Data reports that age is a factor when considering cannabis use as it relates to exercise. Those under 45 had a higher percentage of reported use of cannabis with exercise than those over 45, with the highest (13%), among consumers aged 35-44.
Wellness-minded consumers are also replacing alcohol with cannabis as more than 81% of current users believe that cannabis is safer than alcohol. While only 16% of consumers specifically list replacing alcohol as their reason for using cannabis, New Frontier Data reported 47% have replaced at least some of their alcohol use with cannabis.
Prescription medications are also being replaced for many users. Emerging research indicates that the increased use of cannabis as medicine has had a substitution effect on prescription drug use. Several cross-sectional surveys report substituting cannabis for prescription drugs, of which opioids, antidepressants, and antianxiety drugs are the most prevalent. The substitution of prescription drugs is the most common motive among users of medical cannabis, surpassing substitution rates for alcohol and illicit drugs.
Moreover, state medical cannabis laws in the United States have been associated with a sizeable reduction in prescription drugs, particularly opioid prescriptions, and with fewer prescription opioid-related hospitalizations, lower rates of opioid overdoses, and decreases in opioid-related healthcare costs.
Medicinal qualities in cannabis have created a demand for infused health and beauty products. Antimicrobials, antioxidants, and other therapeutic properties contained in these skin care products are responsible for this segment’s growth, with the United States accounting for or 47% of the $5.45 billion global market, and women comprising twothirds of consumers. An estimated compound annual growth rate of 5.5% will increase the total market value to $10.9 billion by 2030, reported Global Newswire.
When you consider global wellness market values at US$4.5 trillion in 2022 and projected to increase by 2%-4% annually, and global cannabinoid market values at at US$27.7 billion with an annual projected growth rate of 25%, and by offering wellness products in subcategories that are already popular in the hempderived CBD market, estimated to reach $16B by 2025, there is an abundant future for wellness products in the cannabis space. The aforementioned data was reported by the Global Wellness Institute, BDS Analytics, and Cowen Research, respectively. At these cross-sections lies a unique opportunity for brands to develop specific effect-based products to capture their piece of the proverbial pie. ❖
A new year encourages hope and reflection, both of which are useful in evaluating existing cannabis policies at the federal level and what may be expected in the coming months. Significantly, while the industry suffered a loss in the unsuccessful efforts to include the Secure and Fair Enforcement (SAFE) Banking Act in the National Defense Authorization Act, Congress did pass the first standalone piece of cannabis reform legislation, the Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454), which President Biden signed into law on Dec. 2, 2022. However, the legislation has met with mixed reviews among industry professionals, and whether it ultimately benefits medical cannabis research endeavors or serves as an impediment to them remains to be seen.
The bipartisan Medical Marijuana and Cannabidiol Research Expansion Act (H.R. 8454) eases federal restrictions on scientific research by streamlining the application process for approval of cannabis-related studies and simplifies requests for large quantities of cannabis for such studies. Currently, the United States Drug Enforcement Administration (DEA) reviews and licenses marijuana cultivators and grants Schedule I licenses to scientists seeking to study cannabis in clinical environments. The act changes this process by mandating that the United States Attorney General solicit cannabis cultivation applications for research or potential drug development purposes, and imposes a 60-day deadline for approval of research applications. Theoretically, these changes will eliminate the DEA’s current lag times for approval of research protocols advanced by scientists working with cannabis, which have
been known to drag on for years.
Additionally, the act encourages the Food and Drug Administration to support cannabis-derived medications and requires federal agencies to provide a report concerning the “potential therapeutic effects of cannabidiol or marijuana on serious medical conditions.” The act also directs the Department of Health and Human Services to work with the National Institutes of Health to analyze the therapeutic effects of cannabis for epilepsy and other conditions. Further, it will study how cannabis affects adolescent brain development, how it may impact the ability to operate motor vehicles, and determine how to overcome barriers that currently exist which inhibit cannabis research.
Who Grows the Research Crops?
One notable barrier to scientific research concerning the therapeutic benefits of cannabis that has existed for many years arises from current restrictions on the set of federally licensed cannabis cultivators. At present, this pool is limited to the University of Mississippi, which was granted a federal cannabis cultivation license in 1968. Unfortunately, the university has historically produced low-quality cannabis for research purposes, and the product’s inferiority arguably has caused significant distortion in the results yielded from research projects utilizing such cannabis.
While the DEA expressed its intention to expand the pool of growers beyond the University of
available for scientific research is of paramount importance. The language that would allow researchers to conduct studies on cannabis currently sold in state-legal markets, thereby aligning the quality of cannabis utilized in human clinical trials with the cannabis currently consumed by patients and adult consumers in state-legal markets, was removed before the act’s passage by the Senate.
Paul Armentano, deputy director of the National Organization for the Reform of Marijuana Laws, criticized this omission, opining that “[w]hile the Expansion Act is a step in the right direction, the limited variety of cannabis cultivars accessible to federally licensed researchers does not represent the type or quality of cannabis products currently available in legal, statewide markets … The fact that nearly one-half of U.S. adults have legal access to these multitudes of cannabis products, but our nation’s top scientists do not, is the height of absurdity and highlights the need for continued legislative action if we want to more easily study the state-legal products that millions of Americans are actually using.”
Armentano’s astute observation highlights the disconnect that exists between current federal cannabis policies and the cannabis policies
adopted by states with medical and adult use legal markets. Oregon Democratic Representative Earl Blumenauer, co-sponsor of the legislation in the House with Maryland Republican Representative Andy Harris, commented in a statement that “[a]s we have seen in state after state, the public is tired of waiting for the federal government to catch up. More than 155 million Americans — nearly half of our nation’s population — now reside in states where adult use of cannabis is legal.”
Indeed, Blumenauer, founder and co-chair of the Congressional Cannabis Caucus, has worked on cannabis reform for decades. He further observed in his statement addressing the act’s passage, “finally the dam is starting to break. The passage of my Medical Marijuana and Cannabidiol Research Expansion Act in the House and Senate represents a[n] historic breakthrough in addressing the federal government’s failed and misguided prohibition of cannabis.”
Nonetheless, the legislation is not without its critics, and perhaps for good reasons. Vicente Sederberg attorney Shane Pennington has dubbed it “a counterproductive nightmare,” observing that the Act imposes DEA
to avoid licensing any marijuana manufacturers at all simply by refusing to place a notice in the federal register seeking more applications.” Currently, the Drug Enforcement Administration does not have such power over any application.
Pennington also points out that the legislation provides the DEA with the ability to avoid deadline triggers simply by refusing to accept an application as “complete,” in contrast to current DEA regulations under which the electronic filing system deems all applications received to be automatically complete or sends an error message advising of missing information necessary for resubmission.
Private research concerning the therapeutic benefits of cannabis is coming into its own. Recently, the Wana Brands Foundation, led by founder and chief executive officer Nancy Whiteman, awarded a $3 million grant to Johns Hopkins University to help further medical cannabis research. It will be interesting to follow the quality of cannabis available and actually utilized for such research, in light of the Medical Marijuana and Cannabidiol Research Expansion Act. One can only hope that Congress will continue on a trajectory that promotes and encourages significant shifts in federal cannabis policies in this new year. Only time will tell. ❖
We provide reliable & sustainable lighting systems for cultivators throughout the United States with the help of leading manufacturers and engineers familiar with the needs of growers.
LED LIGHTING
ELECTRICAL DESIGN
LIGHTING CONTROLS
TABLES, RACKS, & BENCHES
FOLLOW US FOR MORE INFORMATION
Attitudes around cannabis are quickly changing as more people embrace the plant for its myriad benefits. As more brands incorporate cannabinoids into their product lines to meet increased demand, the wellness category is seeing a paradigm shift. The cannabis beauty category alone is projected to reach a value of $8.86 billion by 2030.
One company setting the bar in this space is Element Apothec. The brand is helping to change the way people think about cannabis by offering a wide range of skincare products, tinctures, and topicals formulated with cannabinoids.
Element Apothec is the evolution of beauty and wellness, putting the plant front and center as a crucial ingredient for the personal care industry — they also have the distinct honor of being a partner in one of Thailand’s first cannabis resorts.
The desire to normalize cannabis as medicine is something Element Apothec Co-Founder and CEO Davina Kaonohi has been striving for her entire life. Her father, a Vietnam War veteran, relied on the plant to help him cope with PTSD. Seeing what a remarkable impact the plant had on him, Kaonohi learned from an early age that the shame and stigmas surrounding cannabis were unfounded.
“We knew when we visited him on the weekends when his stash box was full, it was a good weekend with him,” she recalled. “Even through D.A.R.E. and all the propaganda, he continued to reassure us that he wasn’t doing anything bad and that it was worth it even if he got arrested because he just wouldn’t be able to live life if he couldn’t have cannabis.”
Kaonohi’s sister took the experience to heart, going on to be one of the first medical marijuana dispensary collective license holders in
California. And while Kaonohi helped where she could, it wasn’t until another family member found success with plant medicine that she decided to dive in full-time.
“My great aunt was diagnosed with multiple medical conditions and autoimmune diseases,” Kaonohi said. “Nothing was helping her and she was allergic to a lot of the medications that the doctors needed her to take.”
After reluctantly agreeing to try a high-CBD cannabis oil, Kaonohi’s aunt was soon on an upward trajectory. At the time, there were very few wellness products on the market containing cannabinoids. Recognizing the widespread need, Kaonohi’s aunt decided to create her own line, engaging her niece to build the brand.
“She passed it on with a goal of bringing her products from the kitchen to the world, realizing that they truly made a difference.”
To take Element Apothec to the next level and further the conversation around cannabis and wellness, Kaonohi knew she had to assemble the right team. She tapped Dr. Mavin Singh, a triplecertified gastrointestinal doctor with experience at UC Irvine’s integrative medical practice, as chief medical advisor. She also brought in Dr. Swathi Varanasi, an integrative pharmacist and
cannabis educator, as the chief scientific officer.
The team consulted with dermatologists on their formulations to ensure every ingredient was safe, effective, cruelty-free, and good for the environment. They opted to adhere to strict manufacturing standards, mirroring European, Canadian, and Japanese markets as they go above and beyond those in the United States.
“We wanted to make sure that we stayed really clean and only used plant-based ingredients. There are a lot of ingredients that we can use here in the U.S. that I don’t agree with,” Kaonohi noted, adding that ethical sourcing was also a big concern.
The Element Apothec line quickly evolved to include a range of goods divided into four unique benefit categories: skin health, calming, recovery, and sleep. On the topical side, there’s a balm, lotion, and patches meant to relieve and nourish along with the Belle Visage face serum to moisturize and balance skin.
There are also three effects-based tinctures to help consumers feel “calm, cool, and collected,” “rest, relax, and recover,” or simply “be well.” The latter was specifically designed with cancer patients in mind to help them through their difficult journeys.
“Everyone deserves to be well,” Kaonohi said of the aptly-named tincture.
Element Apothec is ahead of its time on many levels, from its commitment to sustainability and clean beauty to its unique recipes. They were early adopters of minor cannabinoids like CBG and CBN, compounds that have now started to flood the market thanks to booming consumer interest.
“We were formulating with minor cannabinoids before most companies were even thinking about it,” she remarked. “We always look at the combination of ingredients to serve a functional purpose.”
The initial response to the line was astounding, with customers far and wide singing its praises. Element Apothec has already received a fair number of accolades as well; the company’s Nourish body lotion won a Clean Beauty Award in 2022, with the Belle Visage face serum being named a finalist in the same category.
While their initial success was already cause for excitement, the Element Apothec team is also celebrating global expansion, having launched in Europe and coming soon to Japan and Thailand.
The brand recently partnered with The Beach Samui, a luxury boutique hotel on the island of Koh Samui, Thailand, creating one of the first
cannabis wellness resorts in South East Asia. The property has already won approval to have an on-site dispensary, a major feat in a country expected to be a hotbed of cannabis tourism as their newly minted market comes online.
Element Apothec is working closely with hotel staff to build out a full spectrum of wellness experiences and educational opportunities for guests who will have the option to take their morning tea with a couple of drops of cannabis tincture, enjoy a facial or massage with infused lotions, or participate in a variety of healing rituals.
The brand is also planning to add a women’s health line and is currently formulating more skin care products to meet a variety of needs. The brand is also striving to work alongside more cannabis brands to strengthen the industry and the message of plant medicine as a whole, launching a CBD health and wellness training program available to customers and retailers alike.
The rapid growth is indeed thrilling, but for Kaonohi and the Element Apothec family, it’s the ability to give back that’s most impactful. A portion of the proceeds is donated to veterans groups, environmental causes, and several other non-profits, fulfilling the company’s desire to have the most impact. Kaonohi noted, “It’s really important to us to do good for people and do good for the planet as best as we can.” ❖
By Charles Warner
Cannabis & Tech Today works with the top PR agencies, events, and brands in the industry. As such, we get to try out a lot of cool innovations, products, and services, and wanted to take a moment to reflect on some of our favorites from the past twelve months.
This is far from a complete list, but here are a few thoughts on some of the products we really liked. Hopefully, you will too. Also, most of this comes from Colorado so you may not have these brands where you are. Let us know what some of your favorites are and for goodness sake — send us some samples. We will check them out and report back in our next “Best Of” list.
We like gummies a lot. Portable, tasty, and consistent (just don’t leave them in a hot car). The live-rosin options are supreme and we have to give the nod to a couple of brands. Dialed In … Gummies have some slick packaging and offer that full spectrum feeling where you get all the cannabinoids and goodies from the plant, not just the THC. Plus, they have a great QR code so you can see exactly where it’s all sourced.
Speaking of QR codes and packing a nice punch, TasteBudz rosin gummies are well worth checking out as they are made with live rosin extracted in-house. Also, we are big fans of the Wana Tropical Smoothie Live Rosin Gummy. It is a women-owned company with a reputation for quality. You can’t go wrong with the flavor and natural ingredients of the WYLD sativa gummies. They are delicious and we would eat them even if they were just plain old gummies.
We are super stoked to report Ripple is still the leader in portable powder. The company continues to innovate with new products like live rosin QuickSticks you put right on your tongue. The brand also offers formulations for sleep, energy, pain relief, and just pure THC. All varieties are easy to carry with you and mix into your beverage of choice or sprinkle on a snack.
These are not your grandfather’s Cheeba Chews anymore. We checked out their facility — the brand is dedicated to quality and innovation and it shows in Cheeba’s new line of Chocolate Taffy CBH:THC Sleepy Chews. If you need help going to sleep, these are the answer.
Want the opposite of sleep? If a mochaflavored energy boost is your thing, the THCV-charged Mocha Chocolate is portable, perfect, and won’t melt in your pocket like a gummy might. Also, the live rosin flavors are delicious and naturally sourced, so not a lot of fillers and junk.
Veritas has a tremendous line of flower that is flavorful and potent and just oozes ultrapremium buds. They even have a super clever terpene pairing with Oskar Blues Brewery and it truly is a match made in heaven. Garcia Hand Picked is another brand of amazing flower that we were really pleased with from the way it smoked to the pleasure it brought us after. Finally, Native Roots has an Onyx Label line that also makes us feel like we are busting out the good stuff when we want to celebrate with friends.
Select Squeeze makes a line of THC drops you can splash directly into your water or favorite beverage. They are portable and potable so you can control dose and flavor based on what you are trying to accomplish in your beverage. Discreet and the results are legit — we really dig these.
We have two here and it should come as no surprise to the avid reader of Cannabis & Tech Today — they are super high-tech. Hitoki Trident Laser Inhaler is straight out of Star Wars. It literally uses a laser to fire up your flower and makes it easy and fun to draw nicely through its sleek mini-water bong design. This has the wow factor you are looking for and the quality you would expect.
Pre-Roll Automation
Pax is like the Tesla of vapes and now they have a line of fresh small-batch Live Rosin carts that work with the Pax Era and Era Pro. These are easy to use, just like we like it, and the live rosin is as close to perfect as we have found. These things are potent and very tasty with the whole-plant flavor and being strain specific you can get your desired feels with the style and sleek design that comes from a name like PAX. The only issue we had was the live rosin pods eventually gummed up and clogged the pen so you need to make sure you keep it clean.
Not to be outdone, another of our favs is Puffco’s Proxy Dry Herb Vaporizer Limited. This is a sleek and sexy, easy-to-use portable modular vaporizer that can be configured for flower or wax and comes with all kinds of cool attachments to customize your gear. This is truly a beauty and it smokes perfectly as one would expect.
Lemonhaze is the epitome of a smoking-good time as far as golf experience with top-notch networking goes. Smart sponsors and golfer matchmaking by Brian Yauger and his team make this a turn-key experience that should be on top of your bucket list … if you can even get a playing position. Don’t get us started on how nice the courses are and how much business you could get done by sponsoring or attending.
Mini Rocket-Box Pre-Roll Machine looks like a droid from a sci-fi movie and performs just as admirably. Capable of perfectly filling 72 joints in under a minute, this bad-boy is a crowd favorite because of its durability, ease of use, and extreme output. With the STM Canna one-tray workflow, you can seamlessly grind, fill, weigh, and close using the same top loader tray. It’s made in the U.S.A. and comes with client service after the sale. This is the workhorse you need to fuel your pre-roll production. Did we mention they smoke evenly and produce nice crowns with the
Legal cannabis only exists because the plant has medical value. Patients, not corporations, drove the legalization movement. As cannabis becomes an industry rather than a counterculture, businesses must remember to focus on the health and wellness of their clients. Products should be held to the highest standards of safety. It’s the right thing to do, and only those companies with high standards and benchmarks will be prepared to thrive in a global marketplace.
Cannabis & Tech Today spoke with CSQ’s new Technical Director Matt Regusci and ASI’s youngest-ever CEO, Tyler Williams, to understand how standards for the cannabis industry are evolving. ASI is a food safety company that recently merged with Kiwa, a global testing, inspection, and certification company. In 2020, Williams founded Cannabis Safety & Quality (CSQ), a subsidiary to ASI that is the first cannabis certification program to meet Global Food Safety Institute requirements, set to be benchmarked this year. CSQ could eventually become the global standard for cannabis quality and safety.
Cannabis & Tech Today: How does AFI’s experience in the food industry lend itself to cannabis?
Matt Regusci: We are the world’s first accredited certification program for cannabis, specifically. We’ve taken our knowledge from the food and dietary supplement and pharma industries and worked with stakeholders in the cannabis space to tailor-make standards for the industry.
Every food safety standard is benchmarked to this program called the Global Food Safety Initiative (GFSI). It’s the highest level in the food industry. We took their template and we want to be benchmarked to that. It’s a very prestigious standard. Even though it’s specific to
food, we’re adapting it to the cannabis industry and taking those lessons learned from the hundred years we’ve been doing business in the food industry and bringing it to cannabis.
Tyler Williams: Because cannabis is an ingredient in gummies, etc., it is part of the food industry. GFSI is a global entity run by major brands like Nestle that created standards to be implemented globally because these are all global suppliers. That’s ultimately where cannabis will end up — a global product with global distribution. We’re preparing to meet those global expectations.
Ten years from now, if MSOs have a company in Germany and companies in the United States, they can have everybody across the board meeting the same expectations.
MR: That’s one of the big things that we hit on, is the global market. In the U.S., we’re focused on the U.S., or state by state. This [certification] gives not only something at a national level but at a global level.
Canada has legalized it federally. When that happens in the U.S., these types of standards allow for free trade between those two countries, like it is in the food and dietary supplement industries now.
TW: And it allows for free trade amongst the states as well. When interstate commerce opens
up, the same expectations in California will be met in New York and Illinois and across different borders.
C&T Today: Do the standards also apply to concerns around smoking cannabis rather than ingesting it?
TW: Yes. Right now, we have four standards. We have growing and cultivation, which focuses on everything from the growing process all the way to packaging whole flower. We’re looking at safety from inhalables, or if that flower is processed further into edibles. Then we have a standard for extraction. We also have food and beverage and then dietary supplements. Once we get through the benchmarking process, we’ll have a standard for cosmetics and contact packaging materials. Anything that touches cannabis, that’s packaging. We will eventually get to consumption lounges.
MR: Packaging is really, really important, particularly when you’re looking at inhalables, vape pens, etc. Well, where was that glass made?
Are there heavy metals or cancerous agents in that? Those are the types of things we would be looking at as well. It takes the scare factor away from the benefits of what the product can actually do.
C&T Today: Is this something companies might pursue to boost their reputation and customer trust more than anything because many states do not require these certifications?
TW: Yes. Four states require third-party certifications. They won’t specifically say you have to be certified to CSQ, but they’ll say the audit has to meet these types of requirements. The certification body has to be accredited. CSQ inherently meets all those requirements that the states have. It’s mandatory in certain states, but not everywhere. Most of the time, there is an element of, “How can we showboat this to our clients, our customers, and consumers and say that our product is safer?”
Right now, it’s more prepping to get businesses ready for federal legalization and helping meet state requirements. We look at all those local requirements during the audit too. It’s ensuring
you’re making safe, quality products because you should want to do that. Then making sure,
especially for facilities with operations in multiple states, it gives them standardization across the board.
A lot of these MSOs get really big through acquisitions. They are acquiring different facilities with different procedures and ways they do things. What will happen is they’ll go in and say, “Okay, we’re implementing CSQ across the board to get standardization across all these different states and all these different facilities.”
C&T Today: What would you like operators in the cannabis space to understand about implementing safety and quality standards?
TW: We do not charge for our standard. You can go to our website to download it. I always tell people, even if you’re not ready for an audit or to pay for a certification, you can download the standard for free and start applying those at your facilities without paying a penny.
There are no excuses for why your business is not following these types of processes and procedures because, once again, you should want to make your products safe and highquality. ❖
Is a scientist the first image that comes to mind when people think of careers in cannabis? Probably not. But, Cannabis & Tech Today would like to change that perception. The foundations of this sector are science, technology, engineering, and mathematics. To prove it, we’re highlighting a few intrepid cannabis entrepreneurs using their background in STEM to innovate the emerging industry.
I’m an aerospace engineer. Before starting Sorting Robotics, me and my co-founders were working at NASA JPL building robotic systems. I actually built a device that’s currently on the surface of Mars producing oxygen from the atmosphere of Mars on the Perseverance Rover … When I was working at NASA, I was talking to some of my friends who were delivery drivers or bartenders and asked, ‘What can I build?’ Do you think there’s something that the industry needs? And they didn’t know because they weren’t on the manufacturing side of things … We knew a few people at a high level who could see a lot of problems. Then that opened our eyes to the issues and we [realized] this is a huge market. It’s not being serviced at all by the big automation companies that could come in and give the industry what it needs, just because of its legal status.
So we live in a gray area. Startups are a good gray area, and this seems like a good space to be in. So it was more that we were looking for a bigger market. Cannabis was a bigger market. We liked cannabis and we finally found problems that we could solve and so we decided to solve them … We look at cannabis as a specific material handling problem and apply just the first principles approach to solving that material handling problem.
We invest heavily in research because we believe in moving the industry forward … Understanding that you can formulate [products] to be consistent, to be precise, to allow people to have that same experience over and over again, I think helps with the stigma, helps bring up the industry, and also may have more people feeling okay and trying consuming cannabis products who otherwise weren’t …
We’re always looking to innovate and to figure out ways to make the product better. With the ongoing research that we have, we’re still studying absorption rates and seeing if different particle sizes or different ingredients affect absorption. There are lots of interesting things from a food science perspective that we can employ within our current line of products.
Also, something that we’re super interested in right now are minor cannabinoids. So we launched the sleep product with CBN. We are potentially looking at CBG products, THCV. But really understanding from the body of research, what those minor cannabinoids are effective for and what we can potentially use them for to be able to give the consumer a different experience.
OdoBan® and OMNIfogUSA™
have teamed up to provide the perfect product delivery system.
Clean, disinfect and eliminate odors with the OdoBan® concentrate/OMNIfogUSA™ system.
From growers to consumers and everyone in between, OdoBan® products meet the needs of the cannabis industry. OdoBan® cleans, disinfects§ and eliminates odors associated with cannabis.
I grew up in my career in the tech space when Web 1.0 was blooming. So I grew up from Web 1.0 to Web 2.0, to Web 3.0, and for the past, probably 17 years, I’ve been what is now called a user experience and research designer. So, designing products and services in the tech space using Lean UX methodologies and usercentered design methodologies …
So, I’ve always been really curious about how people work and why people do things. My whole goal in the [cannabis] space for UX is creating tools, products, and services that help you do your work, so you have more time to do the things that you love … I’m also starting a [cannabis] project on genetic authentication and putting it on the blockchain.
We need different ways of thinking. We need collaboration. We need folks to arrange all the messy stuff that’s happening — put the jigsaw pieces together. So I would love to see more women on the STEM side of cannabis.
When I joined my engineering company, Siemens, a couple years after getting there, I was lucky enough to start out with a few other people in their energy and environmental services business unit. At the time in the U.S., it was when, from an industrial sector, energy efficiency and sustainability started to become cool. People were making buying decisions on it, based on government incentives, based on consumer preferences. So Siemens decided to jump in, and start their own business unit.
As a result, we got a chance to go around to a lot of different manufacturing industrial facilities and do energy audits and suggest and implement different projects to help with sustainability, reduce energy usage, water conservation, and things like that. So, I just got a great background in it. I really had a good understanding when I got into the cannabis industry, how there was so much low-hanging fruit kind of figuratively as it related to these types of gains, efficiency gains, and environmental improvements. So it was kind of a natural bridge that I was able to cross because of the background I gained in engineering.
Many tribal nations are developing sovereign cannabis operations. Chenae Bullock, a tribal citizen of the Shinnecock Nation in Long Island, New York, has been working in the cannabis space since 2016. When her tribe passed a medical ordinance, it planted the seeds of what would become Little Beach Harvest, a dispensary located in the heart of the Hamptons.
Cannabis & Tech Today sat down with Bullock during MJBizCon 2022 to discuss her plans for the dispensary and how retail cannabis could impact her tribe. This interview has been edited for length and clarity. Listen to the full conversation at cannatechtoday.com/podcasts.
Cannabis & Tech Today: How did Little Beach Harvest come to fruition?
Chenae Bullock: Little Beach Harvest is our tribe’s wholly-owned cannabis business. We got into the cannabis industry back in 2016. Our tribe passed our medical ordinance, and so we issue licenses within our community. We have our own cannabis regulatory division that issues licenses. So Little Beach Harvest has a cannabis license. We don’t need a license from the state of New York, which is where our tribe is located. We’re right in the Hamptons.
We are in the process right now of building our 5,000 square feet dispensary. We broke ground on July 11. We are doing everything from gearing up operations to hiring and looking at different brands. It’s exciting times for our tribe because the main thing is our tribes do not receive a lot of the benefits that most of the social equity groups do in the state.
C&T Today: Would you explain why Native American tribes are not eligible for state programs?
CB: We have our own separate government, so that means that we have to generate our own economic sustainability to sustain ourselves as a tribal nation. So this [dispensary] is exciting because not only is it going to sustain us, but it’s also going to help with mental health. It’s going to help create jobs. I mean, cannabis, it’s just an awesome plant. It’s a healing plant and so that’s something we’re going to be able to provide for our community and others.
C&T Today: What are you most excited about as far as this dispensary coming to your community?
CB: I’m most excited about the fact that it’s going to be in the Hamptons,
but it’s also going to be on Shinnecock land. It’s going to be a retail destination. A lot of people have never been to a tribal reservation. A lot of people are not even aware that there are tribal communities still in New York, close to New York City. So not only is this a place where people are going to be able to come and purchase their cannabis, but it’s also going to be a place of education. It’s almost a gateway to Indian country, if you will.
We are also going to be having a wellness lounge that will be adjacent to our dispensary. So once that is built, that will also be an awesome place for us to be able to hold and facilitate a space for all types of conversations when it comes to indigenous rights, when it comes to cannabis, when it comes to holistic practices, and things of that nature.
C&T Today: What are some of the challenges the tribe encountered while setting up this business?
CB: The challenge with doing anything as a tribe in the state, it takes a government-to-government relationship. So when it comes to our tribes having businesses, we’re not just like any other business. It is a government-to-government agreement that has to be made. And in our case, if we want to be able to buy wholesale from other registered operators in the state, we should be able to do so because they’re able to do so. But because we don’t have a license in the state of New York and our license is essentially issued from the Shinnecock Nation, the state has yet to recognize it as reciprocity.
C&T Today: What would you like people to understand about tribal nations participating in retail cannabis?
CB: People are advocating as people of color to have provisional language in policy. But if you’re leaving out
the “other” — because you have Black, Latino, white, Asian women, and then there’s “other,” a lot of times Native Americans are not looked at as that [other].
States are often just saying, “Oh, well, [Native American tribes] can do their own thing.” Okay, yeah, but what about what we can do together as two governments here?
So when you look at how we govern ourselves on our very same lands, we have always held stewardship not only to the water, not only to the land, but to other humanitarians. So when you’re talking about cannabis, this is a sacred plant to who we are. Not only are we going to enter this industry, we’re reclaiming this industry by being able to do this with our own policies and create our own economies. But that shouldn’t be separate from the overall industry. That should be able to have reciprocity, just like we allow reciprocity on our lands with other departments of the federal government or the state. I don’t think enough people in the overall industry are aware of that. So it’s not that we’re being left out on purpose. I don’t think that’s the case. I think there’s just no awareness of it.
C&T Today: What are you most excited to see on the horizon for Little Beach Harvest?
CB: I am so excited to see our tribe do business at this level. I mean, historically, we are known as whalers. We taught the people in the Hamptons how to whale. The Hamptons essentially were founded on whaling. And since there were so many laws that were made against our way of living, the wealth gap between us as Shinnecock people and the one percenters now that live in the Hamptons has widened. So this is an amazing opportunity for us to be able to sustain ourselves. ❖
“
This is an amazing opportunity for us to be able to sustain ourselves.”
Cannabis culture has long been steeped in advocacy. Between fighting for reform, championing environmental causes, and righting the wrongs of the war on drugs, activism is in our roots.
History aside, cannabis consumers are also inherently empathic, demonstrating higher levels of moral decision-making versus non-consumers. Additionally, key demographics like Gen Z and millennials are also far more likely to purchase products that make a difference when given the choice.
For cannabis companies, having a strong social impact strategy ensures they’re doing what’s right while also catering to the sensibilities of consumers. But what exactly does that mean?
Some base their entire brands around social impact, while others support causes near and dear to their hearts in a variety of ways such as donating a percentage of profits to organizations in alignment with their values or encouraging employees to volunteer. There is no one right way to engage — it’s the mission that’s most crucial.
“If we don’t provide a social impact element to this industry, then history will be forgotten,” said Anthony Alegrete, co-founder and COO of 40 Tons, a cannabis brand dedicated to raising awareness and providing opportunities to those impacted by the war on drugs.
40 Tons is a quintessential social impact brand, inspired by an authentic passion for change. Anthony started the company along with his wife Loriel Alegrete and longtime friend Corvain Cooper. The three had their lives turned upside down in 2013 when Corvain and Anthony were criminally charged for their alleged roles in a cannabis trafficking operation.
Anthony was given two years in prison. Corvain received a life sentence without the possibility of parole. “It’s like, ‘no, this can’t happen,’” Corvain recalled of the day he was
Loriel Alegrete
Corvain Cooper
Anthony Alegrete
sentenced. “I didn’t have any belief in the justice system.”
Once Anthony was reunited with his family, he refused to stop advocating for his friend. He and Loriel, whose mother had found success with medical marijuana during her fight with cancer, worked with Corvain from the outside to create a legal cannabis brand, inspired by a newspaper headline that read, “Man Sentenced to Life for 40 Tons of Weed.”
The idea was to raise awareness for people like Corvain and help others who had gone through the same struggles. “We wanted to make sure that we were first and foremost a social impact brand, and whatever we sold was just ancillary to what we represent,” Anthony explained. “We figured if we can build a community of people around a common cause, that provides tools and resources to help folks, people would want to support that.”
Fortunately, Corvain was granted clemency in January 2021 by outgoing president Donald Trump and released from prison not long after. Now, he works alongside his 40 Tons co-founders as the chief brand officer, sharing his story and bringing attention to the 40,000 people still in prison for non-violent cannabis offenses.
“I want to use my experience as the model,” Corvain said. “We want to help be responsible for saving another life, now that my life has been saved.” 40 Tons sells cannabis flower in dispensaries across California and has done several collaborations with other brands including in emerging markets. They also offer a variety of apparel and merchandise, all bearing the 40 Tons logo.
However, the real work comes in
the form of initiatives through the 40 Tons Foundation, a 501c3 that provides resources for marginalized communities, advocates for prisoners, and provides resources for incarcerated individuals once they’ve been released to help set them up on a path to success.
40 Tons also hosts career fairs with partner cannabis companies, featuring a range of educational seminars, expungement clinics, assistance with resume building, free headshots and haircuts for job-seekers, and even professional attire for those who need it. “It’s one thing getting out [of prison] but now what are you going to do after you get out?” Corvain said. “How can we enable you to help your family and get back on your feet?”
Brands like 40 Tons aren’t just making a difference in the communities they serve — they’re also setting an example in the cannabis industry by bringing visibility to the equity challenges
being faced and reminding us there’s still a long way to go with regard to restorative justice.
“If we’re going to have a legal market, make it fair and give people their freedom,” Anthony declared. Corvain agreed, pointing to the fact that criminalization is far from over. “No one really realizes that people are still currently getting locked up for marijuana charges — awareness is number one,” he added.
For operators wanting to do the right thing and boost their advocacy efforts, it can be difficult to know where to start. The initial discussions can sometimes feel just as overwhelming, but facing hard truths is the first step toward making real change.
“It’s extremely important that people have that initial conversation. Companies must be willing to talk about what it means to be a social impact brand,” said Loriel, who also acts as the 40 Tons CEO.
She recommends seeking out local organizations on the front
lines of causes important to your company’s mission, whether it be social justice, sustainability, or animal rights. “It’s about finding out who’s doing what and where, and then lending your support, whether that’s with your hands or with your pocketbook,” Loriel suggested.
Once your core cause is defined, it’s crucial to keep the mission at the center of brand communications. Encourage customers to get involved and champion your cause whenever possible. From social media to swag, elevate the company’s beliefs from all sides and hopefully, a ripple effect will soon be seen.
At a time when the cannabis industry is facing great adversity, social impact may feel like a lower priority. But if you ask Anthony and the 40 Tons family, the investment is more than worth it.
“Even though we may make less on the front end, in theory, we should be making more on the back end, because we’re helping society,” he said. ❖
“ We want to help be responsible for saving another life, now that my life has been saved.”
– Corvain CooperPhoto: Emily Eizen
Massachusetts: Leading the Way
Massachusetts was the first state in New England to legalize cannabis for recreational use in 2016. In its first year of legal adult-use sales, Marijuana Business Daily reported the state pulled in more than $400 million. Its cannabis market is expected to grow exponentially in the coming years, with a projected revenue of $2.6 billion by 2025.
Vermont: A Pioneer in Legalization
Vermont was the first state in New England to legalize cannabis for medical use in 2004, later legalizing adult use in 2018. The state’s cannabis market is relatively small. However, the industry projected to generate more than $120 million by 2026, according to the 2022 MJBiz Factbook.
Rhode Island: A Growing Market
Rhode Island legalized cannabis for medical use in 2006 and recently approved the legalization of adult-use cannabis in 2022. The state’s cannabis market is in its early stages of growth, with Statista projecting revenue of $167 million by 2025. Rhode Island is home to several successful cannabis companies, including Curaleaf, one of the largest cannabis companies in the world.
70 Cannabis & Tech Today // Vol. 4 / Issue 4
Connecticut: A New Entrant Connecticut legalized cannabis for medical use in 2012 and approved the legalization of adult-use cannabis in 2021. The legalization of adult-use cannabis is expected to provide a boost to the state’s economy, with Statista projecting revenue of $160 million by 2025.
New Hampshire and Maine: Emerging Markets
New Hampshire and Maine legalized cannabis for medical use in 2013 and 1999, respectively. Both states recently approved the legalization of adult-use cannabis, and their cannabis
❖
The cannabis industry in New England is expanding rapidly. With more states legalizing in the Northeast, there is increased demand for analytical testing. Testing is crucial to ensure consumers receive safe, highquality products. This includes testing for the potency of THC and CBD, as well as for contaminants such as heavy metals, pesticides, and mold. Growers, processors, and dispensaries use the results of these tests to make informed decisions about the products they produce and sell. Testing also protects consumers and informs regulators.
However, in the New England region, there are several challenges to creating a comprehensive analytical testing program. One of the main challenges is a lack of standardization. Unlike other industries, the cannabis industry does not have a standardized method for testing, which can lead to inconsistent results and confusion for consumers. Additionally, there is currently no federal regulatory framework for cannabis testing, so states are left to create their own regulations. This can lead to a patchwork of regulations across the region, making it difficult for businesses to comply with all the requirements.
Purpose-built technologies are making it easier to conduct precision cannabis testing. Orange Photonics’ LightLab 3 Cannabis Analyzer can measure small
concentrations of cannabinoids, down to 1.7 ppm. This is especially crucial for edibles and beverages. Orange Photonics Chief Technical Officer Dylan Wilks told Cannabis & Tech Today that pinpoint accuracy is becoming vital for the industry.
“1.7 ppm doesn’t sound that impressive until you realize that’s less than a grain of salt in a 12ounce beverage — not an easy thing to quantify!”
As a wider variety of products hit New England shelves, customers expect accurate test results to gauge potency, purity, and dosage. Wilks said he’s eager to see the industry adopt more stringent protocols for quality testing. “Moving toward manufacturing processes that align with current food and drug production standards will elevate product quality and ultimately allow for safer products for consumers.”
Some New England states, such as Massachusetts, have established strict regulations and standards for cannabis testing, including requirements for accreditation and training for laboratory personnel. Additionally, organizations like the American Council of Independent Laboratories are working to promote best practices and establish standardized methods for testing.
Retailers and producers have more to gain than pleasing regulators and maintaining customer satisfaction. Cuttingedge lab equipment can help a
brand stand out from its competitors.
Wilks noted, “While ‘test’ is a four-letter word for many organizations who want to avoid the cost and complexity of testing, it’s also an area where a producer can truly differentiate. Whether it’s phenohunting for the next big cultivar or catching a quality issue before it becomes a nightmare, having in-house capability is more essential than ever for producers.” ❖
If you could participate in an industry worth $108 billion, would you? Data Bridge Market Research expects the global cannabis edibles market will be worth at least that much by 2029. As manufacturers in New England consider how to make the most of the region’s growing cannabis scene, gummies and cannabis edibles should be among their top priorities.
Edibles made up 12.1% of American cannabis sales in Sept. 2022, according to data analysis company Headset. Gummies were responsible for nearly 74% of those sales. Massachusetts reportedly has the second-highest demand for edibles in the country.
With these numbers in mind, it makes sense more manufacturers and producers are leaning into the edibles market. For many, the only question is how to start and with whom to partner for reliable production.
Making a delicious gummy isn’t as easy as it sounds, just ask anyone who has tried a bad one. But some companies figured out how to do it right. Heritage CBD, a hemp company based in Northampton, Massachusetts, found success with its CBD gummies. Manufacturers in the area caught on and started approaching the founders for the secret behind their best-selling creations.
Heritage Hemp Co-Founders
Sarah McLaughlin and Tim VanEpps saw an opportunity to help producers nationwide create consistent, shelf-stable gummies using their patent-pending processes. The duo created Meltto-Make Gummy Base, allowing manufacturers to add their own botanical blends to an all-natural, tasty base. Melt-to-Make now offers manufacturers a variety of flavors and two options for a base, pectin or gelatin.
The add-your-own distillate approach is especially helpful in New England states like Massachusetts, which prohibits edibles from containing more than 5 milligrams of THC per serving. The distillate must be independently tested, precisely measured, then added to a base before shipping out to retail shelves. Retailers in New England are finding edibles especially popular — perhaps because edibles are one of the few ways to consume publicly.
While most states in New England have legalized, there are very few places to smoke cannabis outside of a private residence. Canna-tourists and those seeking to partake while out and about are more likely to discreetly eat an edible than smoke a pre-roll.
Producers seeking an affordable entryway into the gummy space should find a partner who can support their journey. Melt-toMake Sales Director Kirsten Wedegartner told Cannabis & Tech Today, “We provide SOP
templates, work instructions, equipment lists, and video tutorials along with our gummy bases. This way, producers can focus on their core competency rather than dealing with supply chain issues, expiration dates, and the inventory and carrying costs
associated with typical gummy manufacturing.” Considering “CBD gummies” was the third most-searched food item on Google last year, it’s likely edibles will only continue to grow in popularity as the cannabis scene expands across the East Coast. ❖
Incredible Looking Flower With No Plant
Degradation
• No Flower Shrinkage
• Live Resin Flower
• Preserves Terpenes & Trichomes
• Increases Extraction
Quality & Yields
Drying and curing cannabis are two essential stages in the process of producing high-quality flower. In New England, the harsh and unpredictable weather conditions of the region can make the process a challenge. However, with the right techniques, it is possible to produce buds that are flavorful, aromatic, and potent.
Drying is the process of removing moisture from freshly harvested cannabis buds, which allows for preservation and helps to enhance the aroma and flavor of the buds. The ideal temperature for drying cannabis is between 60 and 70 degrees Fahrenheit, with a relative humidity of 50-60%. In New England, however, the high humidity levels during the summer months can make it difficult to achieve these conditions. To overcome this, growers in the region often use dehumidifiers and air-conditioners to maintain the ideal environment for drying.
VT Dry & Cure Technologies’ Cannatrol System is taking a fresh approach to the process. The company’s twice-patented Vaportrol tech is helping New England growers reduce labor costs and preserve terpenes. VT’s
President and Co-founder Jane Sandelman told Cannabis & Tech Today, “New England is certainly unique! Bone dry in the winter and humid in the summer. When you have wild climate swings, it’s hard to control the post-harvest environment.”
She explained traditional HVAC systems are not designed to dry and cure cannabis. Cannatrol allows users to control vapor pressure to create an ideal environment. “Generally, our customers ask us about the technology and why we use temperature and dew point versus relative humidity. The answer is simple — it’s physics! You can’t control RH because it’s made up of two components: dew point and dry bulb temperature. Our technology gives you independent control of those components. When you have that level of control, you can create a very stable, consistent environment.”
It is important to note that the drying and curing process can be an opportunity for growers to further tailor the flavor and potency of their buds. By using different techniques and adjusting the environment, growers can create unique, high-quality
cannabis products that stand out from the rest. Sandelman noted, “It’s all about the science. The more we can apply real science to our work, the more we can create consistent, repeatable processes. When the post-harvest process is in control, it gives cultivators of all sizes the ability to focus on other areas of the grow.”
cannabis in New England can be a challenging process, with the right techniques and equipment, it is possible to produce buds that are flavorful, aromatic, and potent. By paying close attention to the timing of the harvest and the environment, growers in the region can overcome the challenges and produce topquality cannabis products that are sought after by consumers. ❖
Our cannabis industry experts will design a plan optimized for your needs, utilizing our comprehensive ecosystem of products and services. From Agrify VFUs and Agrify Insights to offerings from our iconic brands—Precision Extraction, PurePressure, Cascade, and Lab Society— we have the innovative hardware, premium software, and knowledgeable experts you need to succeed.
By Sara Brittany Somerset
is arguably one of the most profound thinkers of the 21st century, with contrary opinions that confound his scientific peers. A prolific author of nearly 100 books, including 21 New York Times bestsellers on topics ranging from meditation to longevity, such as Reinventing the Body, Resurrecting the Soul, and Quantum Healing, he is often miscategorized as a “new age” or “self-help guru,” and is criticized by quantum physicists.
As a polymath, Dr. Chopra is concurrently a physician, triptych medical school adjunct professor, and philosopher with a cohort of celebrity pals, including actress Goldie Hawn and CEO of Cybin, Doug Drysdale.
Cannabis & Tech Today couldn’t resist the opportunity to pick his brain. Sara Brittany Somerset chatted with Dr. Chopra over Zoom from her home in Jupiter, Florida, while he was in The Chopra Foundation’s offices in
Tavistock, Lake Nona, Florida.
Cannabis & Tech Today: You mentioned once that psychedelics — and cannabis can be psychedelic depending on the dose — can help people lose their fear of death.
Deepak Chopra: There’s a deeper understanding of that. So, what psychedelics do is twofold. One is that psychedelics loosen the neural correlates of the conditioned mind. So, we’re all conditioned by economics, childhood, religion — you name it. Every experience conditions us so that it loosens the neural correlates of that.
It also turns out that psychedelics actually decrease the activity of a part of our brain called the “default mode network” (DMN). This is the neural correlate of our ego. So, when it loosens these things, you experience who you are beyond the conditioned mind, and therefore there’s comfort in that. That’s one part. Another part is that everything recycles, including plastic. Energy recycles, and matter recycles.
C&T Today: People recycle.
DC: If consciousness didn’t recycle, it would be the only exception.
C&T Today: The psychedelic experience could be a projection, a fantasy of experience.
DC: No, no. What you are seeing now is a projection fantasy. The psychedelic experience was the reality.
C&T Today: After my first ketamine experience, I lost my fear of death.
DC: Yeah, like one of my agents. Lynn Franklin was my agent for many years. She died recently of cancer, and I sat with her with a neuropsychiatrist and MD, Dr. Gita Vaid. It took her a week to 10 days before she died, and she was looking forward to her death.
C&T Today: Was that because Lynn wanted to see what would happen next, or she knew that something would?
DC: There’s something called “terminal lucidity” that happens in some people before they die; some people have it for a few seconds, for a few moments, or even for a few days. I asked my neuroscience friends if that is real or a hallucination. But some of my neuroscience friends said that occurs in about 5% of patients. So what ketamine does is enhance an experience that some people normally have.
C&T Today: Will we one day be able to transfer our consciousness into a machine or an AI?
DC: If it’s infinite, how would you transfer it? Can we transfer the activity of the mind to a computer? The answer is that some activities of the mind can be done and theoretically transferred to a laptop. If you want to open the garage door, you have a thought that triggers the door opening. Or even possibly treating people with paralysis. It would enhance rehab and things like that.
C&T Today: What is your opinion of Elon Musk’s Neuralink?
DC: Limited applications. It’s otherwise a lot of hype. I would say it’s not a bad endeavor because it’ll help people rehab. It’ll help people who are paralyzed. That’s a
great promise. But don’t go all the way to say it’ll change subjective experience. It’s not possible. However, when I read about Neuralink, which could enhance memory or treat depression, I think that’s a fantasy. Because if I ask you anything like a memory, such as, what did you have for dinner last night? Tell me.
C&T Today: Spinach tortellini.
DC: Okay. Now, I will ask you another question. Do you remember any one incident from your childhood?
C&T Today: Of course.
DC: Okay. So, where was that memory before the previous question?
C&T Today: Stored somewhere in the dark or dank recesses of my brain, I suppose.
DC: But inside your brain, there is no experience from your
childhood. When you retrieve a memory, the whole brain involves many separate parts of the brain. They get active in a way that neural networks connect with each other. It’s not limited to one part of the brain. Maybe, one part of the brain gets more active, but it’s a correlated movement. That movement happens at the quantum mechanical level and is triggered by your intention to have that memory. Still, before you had that memory, there was no memory of it in the brain. You reconstructed an experience that is now stored somewhere in your consciousness, which is what recycles. When we talk about reincarnation, that’s what recycles.
C&T Today: I conjured the memory based on your question.
DC: Correct. So that’s what happens. The memories were conjured because you have an intention, or you have a question,
or you see something that is triggered, like a deja vu experience.
C&T Today: It may sound unbelievable, but it’s much easier for me to remember things that happened when I was very young, even two or three years old, than to remember things that happened five or ten years ago — or how long ago certain things occurred.
DC: That’s all very, very good because you don’t want to! Some people remember everything in their lives, and they’re tortured. What we usually remember is what we ascribe emotional significance to. If I ask you what you were doing last Tuesday at three o’clock or what you were thinking last year at three o’clock in the afternoon, you don’t know. Thank God. But if you knew everything you were doing at every given moment, you would
have a tortured brain.
C&T Today: Everybody remembers 9/11.
DC: Yes, and everybody remembers, if they’re old enough, the assassination of John F. Kennedy or Dr. Martin Luther King, Jr. That, or they remember their first kiss or something like that.
C&T Today: So, we remember things that are significant to us and profound human experiences.
DC: Yeah, either good or bad, it doesn’t matter, but they’re highly emotional choices. Yes.
C&T Today: Some people with severe depression have undergone electroshock therapy. One of the side effects is that it creates memory loss. Some would argue that if they can’t remember the things that upset them, they will feel less depressed. In contrast, others become more depressed
“Technology can ultimately create a more peaceful, just, sustainable, healthier, and joyful world.”Credit: Sipa USA / Alamy Stock Photo
OUR ENERGY EFFICIENCY IS MUCH HIGHER AND OUR THICKEST, FULLEST FLOWERING ROOM IS USING FLUENCE FIXTURES.”
– CULTA
because they’ve lost significant memories that made them happy, such as memories of their loved ones. Do you think that is still a valid form of therapy?
DC: No, I do not think it’s a good form of therapy, just like, at one time, they used to perform lobotomies. They cut the connection between the right and left brain, severing the corpus callosum. The future will look at these therapies as medieval and barbaric.
C&T Today: How can technology be used together to create the best health outcomes?
DC: Technology is neutral. How we use it depends on us. Technology, such as cyber hacking and nuclear weapons, can be used for diabolical purposes. Technology can ultimately create a more peaceful, just, sustainable, healthier, and joyful world. And good health.
C&T Today: Do you think psychedelic medicine should be offered to people who are incarcerated?
DC: I think it’s a very valid question, and my answer is yes.
C&T Today: The Chopra Foundation has partnered with Cybin, a biotechnology company progressing psychedelics to therapeutics. What is the driving force of this collaboration?
DC: Cybin and I are both seeking scientific validation of what works and what may not work. There is nothing that we can say is a panacea. Still, psychedelics hold a lot of promise in treating mental and physical illness, terminal care of patients, and much more.
Our mutual goal is to make all
the data and science available to the world, both professionals and the general public.
C&T Today: What is your opinion on CBD? Is it healthy and helpful to reduce inflammation, or is it snake oil?
DC: It is very beneficial to reduce inflammation.
C&T Today: Have you ever tried cannabis?
DC: During my late teens and very early twenties, I was a regular participant in a festival called Holi*, where imbibing a drink called Bhang* was part of the celebratory rituals along with dancing and throwing of colors at each other.
Since then, if I happen to be in India during the festival, I celebrate the ritual with various friends. The ritual is a celebration of divine love and everything about it is an ecstatic experience.
[Editor’s Note: Holi is a Hindu spring festival celebrated throughout North India. It is particularly popular among devotees of the god Krishna. Bhang is an edible mixture made from the flowers, leaves, and buds of the cannabis plant.]
C&T Today: Do you find cannabis beneficial to your patients or you?
DC: I personally find no need to use cannabis. The altered states it brings about are available to me in deep meditation. As for patients, yes, I recommend it in selective cases.
C&T Today: What are the most practical medical applications for cannabis consumption?
DC: Chronic pain relief, treatment for depression, anxiety, arthritis, and inflammatory bowel disease, to name a few. Cannabis is very
useful for these disorders as an adjunct in their management.
C&T Today: Do you believe in the discovery of the human body’s endocannabinoid system?
DC: Yes, this is a very important discovery. If you have a receptor, then obviously the body produces the appropriate ligand. I believe the endocannabinoid system is part of our biological selfregulation system to alleviate inflammation and facilitate homeostasis.
C&T Today: Who would you most like to consume cannabis with?
DC: I have found the celebratory ritual of Holi to be almost an ecstatic experience, and, personally, I’m not interested in using cannabis alone or in an intimate setting with friends.
C&T Today: You’ve thrown a little shade at Elon and clapped back at some physicists. Is there anyone else you want to take a shot at?
DC: Those who call me a lunatic. I
was given the Ig Nobel prize for quantum mechanics, which means “the ignorance of.” So, to all of my critics: Wait for a few years and see what happens!
I hope your article might help my Wikipedia page because they say I’m not even wrong; I’m so off base when I talk about quantum mechanics. They don’t care what the data is. As long as they see something in print, they quote it. Your article will be in print, so hopefully, they’ll see –
C&T Today: The power of the printed word?
DC: Yeah.
Despite his critics, and the dichotomy of his reputation as either a genius or a crackpot, Dr. Chopra’s latest two literary offerings Meta Human: Unleashing Your Infinite Potential, and Living in the Light: Yoga for Self-Realization with yogi Sarah Platt-Finder, demonstrate that as a septuagenarian, he shows no signs of slowing down. ❖
“Psychedelics hold a lot of promise in treating mental and physical illness, terminal care of patients, and much more.”Photo courtesy of The Chopra Foundation
“When you’ve got two human beings hitting each other, there’s no such thing as a hammer and a nail. They’re both hammers. Both people are going to incur some sort of injury,” said former NFL great, Chicago Bears safety Doug Plank.
One half of the Bears’ “Hit Men,” Plank is no stranger to collisions or playing with pain. “Pain is such a factor in the National Football League. When I was there, physicians would drain your joints. They would actually take inflammation out of your shoulders and knees. That’s why I think I’ve got four replaced joints right now — titanium.”
Sixty-nine-year-old Plank walked the floor of MJBizCon 2022 in Las Vegas to learn more about the industry. He wanted to know how it can help former and current players in the NFL recover, deal with pain, and live a better quality of life when their playing days are behind them. Plank recalled how things were when he played: “Thursday or Friday, getting ready to play a game on Sunday, and you couldn’t run because of the pain. Back in the seventies, what would happen between Thursday or Friday and Sunday is that the typical player in the NFL would get injections into his body to make him feel like he
was brand new. He could do anything. You know, all the pain was gone. The flexibility was there like you never had it before.”
In any era of the NFL, injury is a part of a player’s daily reality. In a 2021 report by Science Direct, over the course of the study period (four NFL seasons), 3,025 injuries were reported. Of the 3,025 injuries reported, 582 (19%) occurred during weeks 1-4 of the 2020-2021 regular season.
Finding the necessary painmanagement solution that aligns with the collective bargaining agreement between the NFL and its players has been controversial for decades.
The NFL has had a firm stance on the use of cannabis as a part of its banned substance list. So, players turned to painkillers and opioids to keep them game-ready and pain-free. Plank recalls taking so many painkillers after breaking his ribs, he was completely numb, putting himself in an even more dangerous situation.
“That particular game I didn’t really feel anything from my neck to my waist. I could look and see it, but I couldn’t feel it. I could touch it without any feeling.” He continued, “I’m not trying to act like I’m some kind of strong, fantastic player. There were a lot of players that suffered the same
Let us help you make your infused chocolates look & taste as amazing as they make your customers feel.
For over 40 Years TRICOR Temper Meters have been the Standard to Perfect Temper!
Simple Operation!
Fast and Repeatable!
If your chocolate bars & mushroom edibles struggle with bloom, low gloss or poor snap then contact us today for more information.
www.tricor-systems.com
Model 530injuries, and we’re expected to go out and play with pain. You know, that was one of the things that you were really expected to do.”
As legalization grows throughout the United States, the NFL is taking a closer look at cannabis use for players. During the 2021 offseason, the NFL and the NFL Players Association agreed on changes to the league’s marijuana policy. Players now are only required to test for marijuana once per year at the start of training camp. Players that fail the test are subject to a fine, but not the lengthy suspension they faced in the past. Plank believes this kind of evolved thinking is a long time coming.
“I’m all for anything that can help the present-day athlete perform and perform better, but also do it under a safe and equitable background and plan. This is a great first step.”
Furthermore, in Feb. 2022, the National Football League announced the award of $1 million in research funding to two teams of medical researchers at the University of California San Diego and the University of Regina. The studies will investigate the effects of cannabinoids on pain management and neuroprotection from concussion in elite football players, respectively.
Plank isn’t alone in thinking it’s about time for these possible rule changes. Recently another Chicago Bears great, Super Bowl champion Jim McMahon, shared how cannabis has been more than a Band-Aid solution, but a lifechanging option. After retiring from 15 seasons in the NFL, McMahon suffered severe chronic pain. To deal, he became attached
to pills, claiming at one point he would take 100 Percocet pills a month.
“There are so many uses for this plant,” McMahon said. “Hundreds of thousands of people are dying
from [painkillers], and there’s not one case of people dying from the hemp plant.”
He added, “God got us all off of these [pain] pills we were taking for years. [Cannabis] is a much,
much better thing for us. Everybody has a cannabinoid system in their bodies, and we’re supposed to be using this plant.”
Dr. Allen Sills, NFL chief medical officer, feels it’s crucial to better understand the current options available for pain management. “As with the league’s broader approach to health and safety, we want to ensure that our players are receiving care that reflects the most up-to-date medical consensus.”
He continued, “While the burden of proof is high for NFL players who want to understand the impact of any medical decision on their performance, we are grateful that we have the opportunity to fund these scientifically-sound studies on the use of cannabinoids that may lead to the discovery of data-based evidence that could impact the pain management of our players.”
“I think the results have proven that it could be an effective treatment in certain situations,” Plank said. For current and future players, removing cannabis from the banned substance list could open up a healthy alternative to painkillers. It could help NFL alumni live a more pain-free life after their careers are over.
The new generation of NFL players has been raised in a world where cannabis is not taboo but a part of the global conversation. For alumni like Plank (who has never actually tried any kind of cannabis), McMahon, and many others, education, erasing the stigma of “the drug,” and understanding the health benefits it can have on everything from chronic pain to PTSD is an important next step. ❖
By Jessica McKeil
Cannabis is inherently sexy. As many people have discovered during their experiments, this plant has the truly magical effect of increasing sensation and encouraging new levels of intimacy. And, it is not just your imagination — it’s scientific fact.
Yet, unlike other benefits of cannabis, its effects on libido, orgasm, and connection aren’t widely publicized. While almost every brand seems to market cannabis for sleep or pain, few are selling cannabis for its effects on sex.
It may be time for the cannabis industry to evolve from the tropes of half-naked women on marketing materials to address the elephant in the room: Cannabis is sexy, and more products need to speak to these effects.
In speaking with Jordan Tishler, MD, a cannabis specialist, founder of Inhale MD, and faculty member at Harvard Medical School, cannabis can help increase both sexual
enjoyment as well as function, but only if used carefully and intentionally.
Tishler summarized the fundamentals of cannabis’s role in sex and pleasure. It starts with the endocannabinoid system (ECS), an internal signaling system that manages a host of essential functions like pain response, mood, memory, inflammatory response, and more. It exists throughout the body, including our central nervous system, brain, and organs, which of course, include the genitals.
The primary function of the ECS is to maintain internal homeostasis, or a state of balance. When that balance is interrupted, as we are now learning, cannabis can help return it to normal. This is true for sexual function as well.
Our current understanding of cannabis’ role in sexual function and intimacy focuses mainly on THC, the primary intoxicating cannabinoid. As Tishler described, the intoxicating side effects are not only manageable with small doses of THC but seem to increase the frequency of
orgasms for women and the intensity of orgasms for all sexes.
Beyond the enhanced physiological sensations linked to cannabis, the plant also has a unique ability to increase satisfaction and bonding, no matter one’s gender. Per Tishler, “Some of that is a cognitive, emotional process, but some of it is actually neuro-hormonal.”
Mernine Ameris, poet and founder of the DCbased organization The Sunflower Girl Collective, has begun exploring the effects of cannabis with sex, and seconds the plant’s ability to enhance intimacy and connection. So far on her journey, she’s found that “the skin-onskin contact becomes a little bit nicer, smoother, just more connected in a way.”
For Ameris, even just the experience of rolling a joint with a partner, or, better yet, rolling joints as a form of service to each other, is a way to create an extraordinary connection. It’s like foreplay before the physical foreplay has even begun.
Perhaps cannabis’ calming and stress-relieving nature allows for more openness between two people. Ameris specifically remembers a session where “[i]t really helped with receiving [pleasure] because I used to be terrified of that specific sex act. I was so self-conscious about it, too.” But instead of fear, she felt joyful and powerful during the act: “It felt really autonomous.”
But getting the dose of THC right is critical. Too many puffs or too strong an edible beforehand, and many people have found that, as Tishler put it, “[i]nstead of promoting our sexual activities, [cannabis] tends to just get in the way.”
Tishler further explained, “Women don’t generally tolerate as much cannabis as men do, but in this sexual circumstance, women can tolerate a broader range of dose” because “[m]en may have more trouble getting and maintaining an erection at a higher dose.”
For those curious about introducing THC into their own sex lives, Tishler encourages people to first experiment with THC for solo sexual activities before bringing it into a partnered one. He also suggests keeping it between a five to 20 mg dose, with 20 mg being on the higher end for those with experience and greater tolerance. Five milligrams translates to
one puff from a joint or a dry flower vaporizer.
A final point from Tishler on cannabis and sex is, “There needs to be a clear dialogue between all the involved parties that sex is wanted. There may be limits. Also, that there is cannabis involved and that it’s consensual as well.”
Cannabis, when done consensually and appropriately, is a potent tool for better sex and intimacy, yet few companies are taking advantage of it. And, fewer still are doing it in a manner that includes women rather than just using them for hyper-sexual branding designed for a male audience.
But then there is Her Highness. This is a female-founded cannabis and accessory brand that is delivering products with sex appeal, but without using the outdated tropes we now expect to be associated with cannabis.
Co-founders Allison Krongard and Laura Eisman are leaning into cannabis’ inherently seductive nature by creating products that are feminine yet unabashedly sexy. According to Krongard, Her Highness is striving to “remove the stigma of female cannabis use, and part of that is the stigma of female pleasure.”
This is why their Pleasure Oil stands out. The oil contains a blend of cannabinoids and a medicinal plant extract known for increasing
And it’s not a lube. This is a THC-rich formula (CBD Pleasure Oil is also available in non-legal regions) designed to break the stigma of female pleasure and stimulate “bigger and better orgasms,” per Krongard. As she details, “Instead of this localized orgasm, it starts at the top of your thighs and goes to your belly button. It’s like this bigger experience.”
Her Highness, and particularly products like their Pleasure Oil, demonstrate how the cannabis industry should be exploring the plant’s natural sex appeal. Today, sex and cannabis are both increasingly perceived as positive and even healthy activities — so why shouldn’t we honor this natural connection?
Scientifically and anecdotally, we know that THC can enhance sensation, connection, and orgasm when used in a controlled and consensual way. So, maybe it’s time the industry evolves its messaging to speak about these effects for a broader audience.
Cannabis’ effects on sex represent a substantial and largely untapped opportunity for product development and better branding. A better orgasm and enhanced intimacy shouldn’t be the side effects nobody talks about. They should be celebrated. ❖
Do you know your Medical Marijuana IQ? While that’s not an actual thing, knowing oneself can play a big role in deciding which method of ingestion is right for you. For example, are you new to treating your ailments with cannabis? Does smoking bother your throat? How quickly or efficiently do you metabolize ingredients? The answers to those questions will likely impact how you choose to consume your cannabis.
Another factor in selecting the right modality is knowing which types your state’s government allows to be sold within its borders. For example, some states do not permit medical cannabis flower to be sold in dispensaries in that jurisdiction. Still others, like Ohio, permit patients to buy flower at medical cannabis dispensaries while also prohibiting the smoking of the flower in joints or water pipes. Instead, an Ohio patient may only smoke flower in a vaporizer.
According to a 2022 study published in the journal Systematic Reviews about the impacts of medical marijuana on a patient’s brain, the overall negative impacts of cannabisbased modalities are minor if the doses of THC are low to moderate. While the study included a varied panel of patients who ingested medical marijuana in different ways, the results pointed to its inability to provide exact support for the conclusion.
Dr. Daniele Piomelli, the director of and a researcher with California-based UCI Center for the Study of Cannabis, says the impacts of medical marijuana on a patient “depends on the individual and what they are using the cannabis for.”
Other contrasts include the time it takes for the THC to get to the brain, the time it takes for the brain to get rid of the THC, the ability of the patient’s body to metabolize THC (which impacts its effects), and the overall affects of medical cannabis on the patient.
Are Edibles the Answer?
No matter a patient’s age, medical conditions, and other considerations, the safe use of medical cannabis is of paramount importance. “We are talking about a strong drug, and it must be treated with respect,” Piomelli warned.
Because an edible dissolves into the bloodstream relatively slowly, he advises patients not to overdo it. If a patient accidentally ingests too many edibles, “the only way (outside of medical intervention) to get rid of it is through the normal process.” In other words, the passage of time is the only solution.
Therefore, he says medical cannabis patients should “start low and increase slowly. Know your body and treat it with respect.”
There are three primary cannabis modalities: smoking, vaping, and all manner of edibles. They differ not only in the method of ingestion but also, “the THC is different in each product,” Piomelli noted.
Although Piomelli isn’t aware of any “strong data” about which modality is preferred, he says a patient’s age, medical condition, and familiarity with cannabis impact which they prefer. For example, a cancer patient seeking to increase their appetite may opt to smoke or vape cannabis to obtain faster relief from the medicine than what is provided by edibles.
While there is no hard and fast rule, Piomelli says he has found elderly medical marijuana patients who use it to help them sleep tend to favor edibles. “It’s like swallowing a pill. It’s safe if you don’t overtake,” Piomelli said.
According to Ethan Pompeo, the founder and CEO of Virginia’s Green Valley Nutrition, gummies, candies, and other edibles are “an excellent method for consistent dosing.” However, he prefers tinctures over gummies for patients who don’t want to smoke due to the faster onset associated with tinctures.
“Gummies are processed by the digestive system before producing its therapeutic effect, but tinctures enter the bloodstream via sublingual transaction, skipping the digestive process altogether,” he noted.
The suggested onset time for gummies is two to three hours, with the peak effect in four, says Pompeo. However, those reaction times decrease to one to two hours for tinctures, with the peak effect occurring approximately three hours following ingestion.
smoking medical cannabis. He suggests patients ask themselves why they are choosing to smoke it when doing so could lead to other medical issues.
effects occurring approximately 30 minutes after ingestion, says Pompeo. Still, he cautions smoking or vaping medical cannabis throughout the day is not a good long-term solution for people with chronic medical concerns because medical studies have shown inhaling cannabis smoke can be hazardous to one’s health.
Different from cannabis edibles like cookies or brownies, water-soluble or nano-emulsified cannabis products like juices, drinks, and seltzers offer a faster onset time than edibles due to their enhanced bioavailability, Pompeo added.
Factors impacting how edibles affect a patient seeking relief from THC gummies and other edibles include weight, metabolism, gender, height, attitude, and tolerance to cannabis. Pompeo, who founded his organic CBD company to help him alleviate body tics and other medical ailments, is not a proponent of
His line of products, which include CBD capsules, pain relief creams, edibles, and more are aimed at “patients who don’t want to smoke medical cannabis or be high but want to enjoy the benefits of CBD without the buzz.” If the person ingesting the edible can be patient so it has time to take effect, Piomelli says it is the best method of ingestion at night. “It has no side effects if taken correctly,” he said.
The onset time when medical cannabis is smoked or vaped is mere seconds, with peak
“Smokers take a big breath, really pushing smoke into the lungs and holding the pressure on it,” Pompeo cautioned. “There are safer ways to use cannabis,” says Dr. Alan G. Kaplan, a Canadian physician with expertise in respiratory health and the author of a 2021 study of cannabis and lung health.
However, Piomelli argued, “pot smoking is not associated with lung cancer but it is with COPD, also known as emphysema.” A patient with sensitive lungs should also refrain from smoking or vaping. Moreover, he says, vaping adds another layer of complexity. That is because the THC is dissolved into a liquid mixture. Sometimes, those liquids irritate a patient’s lungs. “We have a better understanding of the impact of smoking cannabis on the lungs than we do of vaping it,” he noted.
All things being equal, Piomelli says there is one modality he believes to be the best. A quality dry-herb vaporizer, which generally costs between $100-$200, is what he suggests. That is because the patient “always gets the same amount. They can also regulate the volume and regulate temperature,” he says. “There is a substantial difference in the way the drug affects the body depending on the route of administration,” Piomelli concluded. ❖
According to the 2021 National Survey on Drug Use and Health, one in five Americans consumes cannabis. With more people making the plant part of their lifestyle, the demand for cannafocused experiences and consumption-friendly lodging has grown exponentially.
Cannabis Travel Association International (CTAI), a 501c6 organization uniting the global canna-tourism sector, found that the vast majority of consumers are interested in plant-centric experiences even if they haven’t yet taken the leap. The 2022 CTAI Cannabis Travel Report revealed that over 70% of those polled expressed a desire to tour a cultivation site, take part in a gourmet-infused dinner, or treat themselves to an infused massage.
“One of the reasons people engage in cannabis travel is to immerse themselves in the culture and heritage of cannabis itself,” said Laura Hand, CTAI marketing chair. “Another reason is they are passionate about wellness and experiences. Cannabis allows them to enjoy activities in a whole new way.”
The enthusiasm around experiential cannabis is not going unnoticed by certain communities who wish to attract this specific demographic and their valuable tourist revenue, looking to cities like Amsterdam and Barcelona for inspiration.
The announcement of the first weed-friendly
hotel in Las Vegas was met with great fanfare, with similar properties expected to open soon. Kansas City, Missouri is planning an entire cannabis entertainment district once adult-use sales come online while destinations like Los Angeles and Modesto in California establish their very own canna-tourism programs highlighting the area’s many dispensaries, farms, and plant-centric excursions.
But cannabis tourism doesn’t just benefit consumers and the places they visit — it also normalizes the plant overall, and helps bring visibility to some of the issues facing the industry today.
Seeing exactly where their cannabis comes from is a big draw for many consumers. To be amidst vast fields of towering and fragrant plants is something many only dream of, driving the growth of cultivation site visits across the country. Some companies, like Emerald Farm Tours and Colorado Cannabis Tours, will shuttle you to locations, offering a full day of fun. However, many farms offer a more immersive experience.
Sol Spirit Farm is one such place. Nestled in the iconic Emerald Triangle, the earth-conscious farm offers all-inclusive glamping visits, retreats,
and events. The experience includes farm-to-table meals using ingredients grown on the property, in-depth tours showcasing the regenerative sun-grown cannabis life cycle, and of course, plenty of chances to enjoy the fruits of the earth.
Co-founder Judi Nelson wanted to create an opportunity for people to get away from it all, and at the same time gain perspective on ecofriendly practices during their stay.
“What inspired me was really wanting to provide a place for people to get out of their normal lives and come reconnect with nature,” Nelson told Cannabis & Tech Today. “And then also wanting to help people see regenerative farming and permaculture lifestyle to inspire people to up their sustainability game in daily life.”
Nelson also strives to enlighten guests on the cannabis supply chain, encouraging them to ask, “where exactly did my bud come from?”
“I’ve had people over the years who come and say, ‘I pretty much just buy whatever the budtender recommends, or I just buy whatever is the top shelf’ and they don’t even actually know whether they’re buying indoor or sungrown — they don’t know anything about what went into that flower!”
At a time when legacy farmers in the famed Emerald Triangle are struggling to make ends meet, the conversation is necessary for consumers to truly understand how their purchases can impact people like Nelson, especially if they consider themselves to be champions of small business.
“It’s really fun when you can open somebody’s eyes, letting them know if they choose regeneratively farmed sun-grown, it’s this kind of an experience where it’s often a small, familyowned farm,” Nelson said.
Canna-tourism is not only an excellent way for consumers to connect with the plant on a deeper level, it’s also a chance to win hearts and minds in the quest for reform.
“By providing a safe and educational environment for people to learn about and experience cannabis, canna-tourism can help to reduce negative stereotypes and increase understanding and acceptance of the plant,” Hand noted.
Offering a secure and inclusive environment rife with learning opportunities is one of the main missions at Coral Cove Wellness Resort, a plant medicine-friendly destination in Little Bay, Jamaica. Visitors can integrate cannabis and/or mushrooms from an on-site dispensary into their vacations under the guidance of nurturing and open-hearted staff.
“Safety is the most important thing while guests are there,” said Keiko Beatie, Coral Cove’s director of education & outreach, who emphasized the importance of respecting each individual’s needs and desires. “Everybody’s journey is different. We should be able to give people the ability to adapt to their level of growth, especially with plant medicine.”
She added that for many relative newcomers, having these types of experiences can be intimidating and incredibly vulnerable. This has led the Coral Cove team to do whatever they can to help prepare guests mentally, physically, and spiritually, whether that means advising on what to eat prior, to offering wisdom for integration after.
“Knowledge creates a safer space within one’s own mind,” she proclaimed. “You’re able to walk the walk and talk the talk because you were educating yourself about this natural type of medicine.”
Beatie agrees that evolving people’s awareness and understanding of plant medicine through tourism will not only help the consumer and the community but also encourages dialogue that could end up having a ripple effect reaching far and wide.
“I really believe that we will all have the capability to receive manna from heaven, to expand our horizons, and hopefully, be at a point in time where we feel comfortable with sharing about it so we may be able to assist or inspire others to want to see what they can do for themselves.” ❖
What are the effects of antimicrobial solutions on cannabis cultivation and production? The cannabis industry is growing at an explosive rate and the regulations governing the cultivation, processing, and distribution are rapidly evolving. They’re also highly fragmented on a state-by-state basis. With increasing competition, cannabis operators are under tremendous market pressures to decrease costs and increase product differentiation even as they face increasing regulatory scrutiny.
One of the key threats to most cultivators are microbial pest pressures from molds, mildews, fungus, bacteria, and other pathogens that can damage crop value or make it noncompliant and unsellable. Consequently, Terra Vera has studied the effects of various antimicrobial solutions generated electrolytically using commonly available salts and amino acids when used on crops at various stages from propagation to post-harvesting.
Data were collected to assess the ability to control common pathogen threats such as powdery mildew (PM) and similar contamination as well as effect on product quality. Observations also include data on overall room cleanliness, efficacy, root propagation times, and operator safety impact. Recent results and statistically analyzed data from relevant R&D efforts will be shared. Finally, worker safety and
environmental sustainability impacts of these treatments will be shared.
It is a daunting task to rid the world of the toxic chemicals that are damaging the environment and contributing to a public health crisis. Simply put, there must be a better way to treat crops, the planet, and our bodies. Countless studies have linked pesticides to cancer, Alzheimer’s disease, ADHD, and birth defects, and they pose serious risks to our nervous and reproductive system functions. They are polluting fresh water sources and creating havoc in biological and wildlife ecosystems.
Terra Vera is investigating a superior alternative that mimics the human body’s natural immune system. Using biomimicry technology, the product of electrolysis of a precursor containing amino acids and salts in an electrolytic cell can simulate nature’s cellular response to stress by creating activated amino acid solutions. (For more information about the electrolytic technology see reference [1]).
Terra Vera observed that these solutions can efficiently deliver nutrients to roots, stalks, and leaves while creating a difficult environment for pathogens.
Because the chemistry can be generated on-site and on demand, it drastically reduces carbon footprint and eliminates the
plastic landfill waste associated with traditional chemical delivery. The authors feel this technology can have a significant impact on the world and particularly cannabis (and related crops such as hemp and hops) agriculture. This is especially important for indoor and multi-level tiered growth environments where pathogen pressure can be the heaviest.
In the legal cannabis industry, it is understood from experience that one of the key challenges inhibiting growth was the inability of cultivators to gain efficiencies and economies of scale to both reduce costs and improve production quality in a safe and sustainable manner. Cultivators in this industry face the same basic challenge as growers of other crops, namely the need to protect crops from unwanted pests and pathogens while maintaining safety and compliance. For cannabis growers, the challenges can be even more daunting as they often grow indoors or in greenhouse settings, making crop infestation a major concern.
A subset of the co-authors were experienced in a unique technology that generates chemical reactions on-site and on demand. The technology was originally developed by the U.S. Department of Defense and Department of Energy for use in water treatment to disinfect for unwanted and potentially harmful
pathogens, including viruses and bacteria. Over time, this technology was spun into use in U.S. E.P.A. regulated water treatment facilities as well as a host of commercial applications.
These co-authors developed a major variation of the technology that mimics our immune system. This new chemistry is highly effective against a broad spectrum of pathogens but is safe and will not harm plants, people, or the environment when used properly. When the needs of the cannabis industry to control biological contamination were paired with the new capabilities of the water treatment, the technology was conceived. After the technology was tested on several crops, it became clear that it could both remediate and prevent some of the more common biological pest issues that often damage or destroy crop value. The technology works on cannabis and would potentially work for other agricultural crops such as hops, hemp, strawberries, cabbage, and wine grapes.
Aqueous solutions of amino acids and salts are activated in an electrolytic cell. As noted above, the electrolytic cell apparatus is described at reference [1]. Various dilutions of these solutions are foliarly fogged or sprayed on a variety of cannabis cultivar plants during growth and post-harvest as well as their grow facilities (see Figure 1) and wiped on work surfaces and plant leaves to demonstrate powdery mildew (PM) remediation (see Figure 2).
Other dilutions of these solutions are foliarly sprayed on cannabis clone cuttings at several points during cloning and demonstrated faster root production (see Figure 3). Some surfaces of plants were wiped before and after treatment with Sani-Check swabs (see reference [2] for details on how to use these swabs) and incubated in an oven typically for 48 hours at 80 degrees Fahrenheit to promote pathogen growth.
Photos of the Sani-Check swabs (and others of plant leaves) were taken with a standard cell phone. Clones were typically cut from mother plants at a 45-degree angle and propagated in a traditional clone dome on a heat mat set at 75 degrees Fahrenheit. Clones were foliarly fed with TV solutions at various dilutions or (in the case of Control cuttings with Clonex solution), (see Figure 4 for one clone showing massive root propagation at Day 15 of cloning). Experimental results are provided with description in the corresponding four figures.
Conclusions
Naturally occurring amino acids and salts when electrolyzed treat powdery mildew and molds as demonstrated by plant photos and swab results. They also serve as a nutrient for accelerated root growth during propagation cloning in a traditional clone dome. Finally, these electrolyzed solutions are safe for workers (with no re-entry interval and minimal PPE required), are safe for the environment, and can be produced sustainably on-site at agricultural farms, eliminating supply chain disruptions.
Rare
and exotic feminized strains
10 Seeds per pack.
10 regular or 5 feminized seeds
FREE with orders over $150.00.
101 Strains available!
REEFERMAN GENETICS
Reeferman is a leader amongst a growing number of Canadian Seed Producers.
SEVEN cup winners, High times and High Life Cups!
MONSTER BREEDERS
Monster Breeders Assoc Inc is a joint produc tion, combining some of the world's best (and biggest) medicinal marijuana Cultivators, Cannabis breeders and researchers under one umbrella.
Cannabis Seeds — Switching your grow from vegetative to flowering light cycles is so old school. Step into 2023 with autoflowering seeds that, as their name suggests, do the work for you. Rocket Seeds new Tooth Decay strain combines Sweet
Tooth 1.1 F2, Blueberry, Grapefruit, and an unknown Ruderalis Fx to offer an indica-dominant hybrid with surprisingly good yields indoors or outside. Known for its happy, creative effects and long-lasting highs, this sweet-tasting strain offers a short flowering time and up to 19% THC. 5
Seeds for $65
Hitoki Saber — This is how you would smoke if you lived on the USS Enterprise. Laser combustion sets Hitoki apart from the competition. It’s portable, compact, and wildly futuristic. Lighting your flower with a laser offers a clean, smooth hit and looks sleek at the same time. While the Saber is recommended for use with the Hitoki bubbler, you can attach it to any glass rig for an otherworldly smoke session. $300
Melt-to-Make™ Gummy Base — Create your own delicious, commercial-grade edibles in just four steps. Choose between 16 flavors of gelatin or 11 all-natural flavors of pectin, add your concentrate, pour into molds, and finish with the provided sanding sugar. Once gummies are set, you’re ready to sell. Melt-to-Make’s all natural, professionally-formulated gummy bases are produced in a GMP-Certified, FDAregistered facility with rigorous quality-control procedures so you receive consistent product in every order. Bulk pricing available. $.02-.03 per gram.
Grön Pips — What’s so innovative about these candy-coated, infused chocolate pieces? They taste like regular candy rather than chocolates with a weed center. These craveable little morsels are infused with 5mg THC and available in a variety of cannabinoid ratios. The bad news? They’re only available in five states (Arizona, Missouri, Nevada, Oklahoma, and Oregon). If you can get your hands on them, devour them, savor them, and give some to your friends in edibles manufacturing so they can learn a thing or two. $15-20
STM Canna Cone Lander — Are you ready to hire your best employee? STM’s newest addition to its line of preroll automation systems loads 72 pre-rolled cones in seconds. Whether used as part of STM’s one-tray workflow or independently, the Cone Lander is reducing labor costs and increasing production. Manufacturers can look forward to one-button operation paired with durable, easy-to-clean aluminum and steel construction. STM includes a one-year parts and labor warranty in addition to the company’s top-rated customer service. Learn more at stmcanna.com.
Laundry Day Cube Grinder — For those seeking an understated, minimalist vibe in their cannabis accessories, the Cube checks all the boxes. Its simple construction allows it to rest in an upright or angular position. Four detachable compartments utilize magnetic closures to separate the top two grinding portions from the ground herb chamber and lower kief compartment. A dainty aluminum scoop helps pack your pipe while you enjoy the soothing aesthetics only Laundry Day can offer. $120
Cannascape
Fresh-Port Technology — These aren’t your ordinary stash jars. Cannascape’s new line of containers feature an inner Airscape lid integrated with Fresh-Port technology. The Airscape lid is pressed down, forcing air out, while the Fresh-Port introduces inert argon or nitrogen gas to displace any remaining oxygen. The result is perfectly protected terpenes and cannabinoids so every bud can stay as fresh as the day it was stored. Glass jars are available in either 4-inch or seven-inch sizes. $43-47
Through Better Data.” Predictive, customized DNA testing offers crucial information about genetic makeup, helping people improve their health and quality of life. A privacy-protected patient portal allows users to analyze their DNA and explore custom cannabinoid formulations for their specific genetic profile. Find the ideal terpenes and cannabinoids in minutes instead of months with personalized wellness plans and comprehensive reporting so you can confidently make the best decisions for your health. $199
PAX Plus — This unassuming vape device does it all. Whether it’s terp-laden dry herb you’re smoking or a sticky, silky concentrate, the Plus has you covered. Unlike the original PAX, the Plus offers four Experience Modes to customize your sesh: Stealth, Efficiency, Flavor, and Boost. Its new 3D oven screen is easier to remove and a redesigned multi-tool and brush allow for quick, easy cleaning. Now available in four colors, the latest offering from PAX offers 2+ hours of battery life and a 10-year limited warranty. $250
The Capsule Bong might be low tech but it’s high class. A modern, clean aesthetic ensures you won’t want to hide this piece away. Take it apart for easy cleaning and better, yet, it’s dishwasher safe so you can say goodbye to traditional cleaning methods. Shatter-proof borosilicate glass, stainless steel, and anodized aluminum add to this elegant bong’s durability. Now available in six colors: black, gray, white, green, pink, and blue. $175
6-Strain Cannador With Nook and Drawer — Store your stash safely and discreetly in Cannador’s humidity-controlled case. A mahogany interior and a walnut veneer exterior protect your smoke while six ¼ oz glass cups keep flower organized. Each removable cup features an adjustable lid that slides open to allow moist air from the humidity system to circulate. Lock the top and the drawer to keep contents secure while VaporBeads maintain the perfect environment for preserving your buds. $289
combines all the features of an electronic nectar collector with an enail and rolls them into one device with a built-in airway valve that functions as a carb cap for any of the available formats. $150
a serious dab enthusiast,
Zeus Arc GT — The Arc’s 35000 mAh battery offers 90 minutes of powerful dry-herb vapor production in a polished, pocket-sized chassis. A gold chamber and gold vapor path set this powerful vape apart from its competitors and thanks to innovative German engineering, the device comes equipped with upgradeable firmware. Does a vape need an accelerometer? Who knows, but the Arc comes with one. Plus, haptic feedback lets the user know when their perfect hit is ready to go. $180
Dr. Dabber XS Nano
Portable Vaporizer — The latest innovation from Dr. Dabber comes in the form of a 4-inch eRig. Its compact design is ideal for the “on-the-go” concentrate dabber. Load up the atomizer with your preferred wax or budder and enjoy a smooth hit thanks to a splash-free water filtration system. Precise temperature settings combine with an intuitive design to ensure each puff is smoother than the last. $160
Smoke Honest Stash Case and Lighter Duo — This modest pairing is perfect for any joint lover’s arsenal. A sleek, slim lighter conceals a hollow tube perfect for a dog-walker size pre-roll — plus it’s waterproof and airtight. The petite lighter is wind-resistant with a replaceable flint. Running out the door for an adventure or heading to your in-laws for dinner, you never know when this little beauty will come in handy. $30
RollBotz RoboKone Filler by Wakit Grinders — Mill with speed and precision thanks to the RoboKone’s bead chain design and rechargeable motor. This precision cone filler gently mills flower to an even consistency before an internal vortex pushes the material down into the cone. This is an ideal accessory for those with dexterity problems or arthritic hands. Just press the button and enjoy a packed cone seconds later. $150
We’re back again for another year at the Fontainebleau Miami Beach. At our conference, you’ll enjoy exclusive opportunities for curated 1:1 networking, access to private dealflow, and hear directly from the executives of top-performing cannabis companies.
“If you are a CEO, have a company that is in the ancillary space, are an investor, or just want to learn what’s going on in the cannabis industry, this is the palce to be.”
—Kim Rivers, CEO, Trulieve“I would highly recommend Benzinga for any new company or existing company that’s trying to get into the space that wants to have a good 2 or 3 days of getting to reach pretty much everyone who means anything in this industry.”
—Chad Bronstein, Founder & CEO, FylloSAVE 30% OFF TICKETS
Colibri Quasar Table Lighter — Elegance and functionality are the cornerstones of this tabletop conversation piece. Triple flames pair with fast, single-action retracting doors for a steady, consistent lighter you can rely on. Rubber foot pads keep it firmly in place without scuffing the table or desk and its pyramid-shaped body tells the world you’re a cannasseur with style. A two-year warranty ensures users get their money’s worth from this refillable butane table torch. $177
Beed Machine — This fully automated appliance is like a Keurig for cannabis. Drop in a cone, pop in a Beed capsule full of fresh, fragrant flower, and twenty-seconds later you’re enjoying a perfectly rolled pre-roll with just the push of a button. Now available in five colors: pink, mint, gray, red, and black, this table top device is your own personal joint roller. $199
G Pen Hyer Vaporizer — Yes, it’s another eRig. But this unique device puts the “tech” into Cannabis & Tech Today. It’s a dual use, portable rig for use with dried herb or concentrates. It pairs with any glass-on-glass water piece. Start your sesh in just a few seconds with a three-button system offering constant temperature output thanks to smart heating technology. The whole package is protected with anodized aluminum for exceptional durability. $250
Puffco Proxy Desert Kit — Tradition meets innovation in the Proxy’s elegant, ergonomic glass vaporizer pipe. Its removable base allows users to customize their piece with compatible Puffco accessories or add flare from a third-party glass artist. The device features four precision heated temperature settings so dabbers can hone in on the perfect level of vapor production. $299
For those who don’t know, Portland, Oregon is a very, very rainy city. If you have the means, try to get at least a day or two out of town, somewhere with bright blue skies and some sun. It’s a game changer. On one of my getaways, I traveled with my friend Janet to Palm Springs. Glorious. On this particular trip, we went to the local farmer’s market where I discovered golden milk. I was headed there for a date shake (see recipe below) but ended up with the spice mix that has changed my winter health and wellness routine.
Golden milk is a blend of spices dissolved in your choice of milk product. I love it with oat milk, but any milk goes. Turmeric is touted for a variety of health benefits including improvement of memory, lessening inflammation and joint stiffness, and reducing the risk of cancer and heart health. Plus, it’s comforting and delicious.
Regardless of where you live, hot or cold, dry or wet, this drink is the epitome of comfort. I’ve started my day with it and have sipped it during my nighttime bath. It keeps for about five days — make a bunch and drink as needed!
One of my favorite recipes from my book The Cannabis Apothecary, this drink was a relatively recent discovery and is now a mainstay of my coldweather remedies.
Serves 2
What You’ll Need:
• 2 cups milk of your choice
• 1-2 tablespoons sweetener (maple syrup, sugar, agave, honey)
• 3 teaspoons turmeric
• 2 teaspoons infused coconut oil, 5mg. THC per tsp.
• 1 teaspoon ground ginger
• 1/2 teaspoon cinnamon
• Pinch white pepper
Directions:
1. In a medium saucepan, combine the ingredients. Allow the mixture to come to a gentle simmer, whisking frequently.
2. Divide the milk between two cups, and sprinkle with ginger or cinnamon.
Serves 2
• 2 teaspoons canna-oil
• 8 pitted dates
• 1/3 cup whole almonds
• 2 cups milk of your choice
• 1 small frozen banana
• 1/2 cup oats
• 1/2 cup almond butter
• 1/2 teaspoon almond extract
• 1 tablespoon maple syrup
Directions:
1. Heat the canna oil in a small skillet over medium-low heat. Add the dates and the almonds and sauté for 4-5 minutes. Set aside to cool.
2. Place the remaining ingredients in the blender and add the dates and almonds, making sure to scrape the oil into the blender.
3. Puree till well blended and divide between two glasses.
Laurie Wolf is the author of such cannabis cookbooks as Marijuana Edibles, HERB, The Medical Marijuana Dispensary, and Cooking with Cannabis. Her recipes have been featured in High Times, Dope Magazine, Culture, and more. She is also the founder of Laurie + MaryJane, an edible company offering everything from almond truffle bites to vegan chocolate cookies. And remember, #Don’tFeartheEdible and #eatyourcannabis.
MARCH
1-3 | The Emerald Conference | San Diego, CA
3-5 | Alternative Products Expo | Fort Lauderdale, FL
9 | ICBC Barcelona B2B | Barcelona, Spain
10-12 | NECANN | Boston, MA
29-31 | NoCo9 - Ninth Annual NoCo Hemp Expo | Colorado Springs, CO
APRIL
11-12 | Benzinga Cannabis Capital Conference | Miami Beach, FL
MAY
11 | Regenerative Cannabis Live | NYC, NY
24-26 | ExpoCannaBiz Business Conference | Cartagena, Colombia
Can’t wait for the next cannabis event? Scan now to discover what’s happening worldwide with the Cannabis & Tech Today Events Calendar.
In the spirit of springtime, Cannabis & Tech Today is thinking green. In the cultivation and sustainability issue, we’ll highlight the companies putting the planet first. The winners of the annual C&T Today Sustainable Leadership Awards will share their strategies for eco-friendly expansion and explain how profit doesn’t have to coincide with pollution and profiteering.
Washington was (technically) the first state to legalize adult-use cannabis consumption and sales. In the eleven years since legalization, that state has flourished into a robust, unique cannabis marketplace. In this issue’s Regional Spotlight, we’ll explore the laws, businesses, and people making Washington one of America’s most fascinating and lucrative regions for cannabis entrepreneurs.
ESG isn’t a four-letter word in the cannabis space. It’s a vital part of putting together a sustainable industry. Investors love to see comprehensive ESG reporting and consumers are hyper aware of how their dollars impact the planet. We’ll take a look at the companies doing it right and explore how customers and business owners can incorporate more ESG into every day decisions.
New England Cannabis Convention
Hynes Convention Center
Boston, MA
March 10–12, 2023
Vermont Cannabis & Hemp Convention
Champlain Valley Expo
Burlington, VT
May 6–7, 2023
Connecticut Cannabis Convention
XL Center
Hartford, CT
May 20–21, 2023
Maine Cannabis Convention
Augusta Civic Center
Augusta, Maine
August 12–13, 2023
New Jersey Cannabis Convention
AC Convention Center
Atlantic City, NJ
September 8–9, 2023
New York Cannabis & Hemp Convention
Albany Capital Center
Albany, NY
September 29–30, 2023
Illinois Cannabis Convention
Schaumburg Convention Center
Chicago, IL
June 2–3, 2023
For info on exhibiting, sponsoring, speaking, or attending, visit: necann.com
CATEGORIES INCLUDE:
At Cannabis & Tech Today, we honor those going above and beyond to be champions of sustainability. From sustainable growing practices to eco-friendly packaging and every other step along the way, you deserve to be celebrated!
The Cannabis & Tech Today Sustainable Leadership Awards offer the opportunity for your organization to be recognized as a leader within the cannabis industry through 2023 and beyond.
It’s easy to enter. Winners receive print and online exposure, an engraved crystal trophy, and digital assets for even more impact.
All applications must be submitted before April 22, 2023, and winners will be announced in the Cannabis & Tech Today
IT’S A SENSE OF COMMUNITY LIKE I’VE NEVER SEEN BEFORE!”
YVETTE, CEO & FOUNDER, REVOLUTION EMBASSY
This year marks the thirty-fifth anniversary of Coco, the first chimpanzee to chief up in outer space. Coco defied all odds and showed the American people no distance is too far, no dream is too big, and no blunt is too fat. The moment historians now refer to as “the blunt smoked around the world” marked the end of a decades-long space race between the United States and the Soviet Union and the beginning of the golden age of good hangs.
On Oct. 4, 1957, the Soviet Union launched Sputnik, the first artificial satellite to orbit the earth. On Oct. 5, 1957, NASA responded by launching a praying mantis on CBD. The goal between both nations became obvious. Who would be the first to send a monkey into outer space to puff on that loud?
Coco, a svelte chimpanzee with an exceptionally chill attitude, was sent from the jungles of Peru to NASA headquarters in Houston, Texas. Coco and 54 of his chimpanzee peers
took part in a rigorous selection process to determine who would pilot the capsule. Scientists tested the cohort’s immune sensitivity, aerobic conditioning, general good vibes, and reaction to psychedelic rock b-sides. Coco, an immediate standout, passed with flying colors, even showing the scientists a few deep cuts they had literally never heard of.
Once selected as the official stoner ape for the nation, Coco worked tirelessly to improve his physical fitness and ability to roll thick blunts while experiencing zero gravity. On the day of the launch, millions of Americans tuned in to see Coco boldly go where no man, primate, or praying mantis had smoked before. Who can forget the day Coco stood on the launch pad and gave news cameras from across the globe the infamous “Coco Sip,” a combination of the hang loose and chief up hand signal. This event marked a major milestone in television broadcasting history as it was the first time the public could see a dank sativa
glimmer in technicolor from the comfort of their own homes.
It only took 14 minutes and 52 seconds for the fearless Coco to leave our atmosphere and four minutes and 43 seconds of licking his blunt to change the world as we know it. Back in Cape Canaveral the control room cheered in joy and popped champagne as mission control proudly declared, “Coco is blazed. I repeat. Coco is blazed.” This quote would be proudly plastered on the front page of newspapers from Houston to Shanghai and also went on to serve as inspiration for Tom Hanks’ character in the 1995 film Apollo 13
Scientists and stoners alike have lauded this moment as “monumental” and “straight up like a movie dude.” If only Coco could see the impact he made on the world today, but sadly he died in 2011 at his Manhattan penthouse surrounded by friends and family after a long battle with syphilis. ❖
